| EOS-AX6963 | INDY | 1169755-45-6 | C12H13NO2S | 235.3 | CCN(/C1=C([H])/C(C)=O)C2=C(S1)C=CC(O)=C2 |
| EOS-AX6964 | ProINDY | 719277-30-2 | C14H15NO3S | 277.34 | O=C(C)/C=C(N(CC)C1=C2)/SC1=CC=C2OC(C)=O |
| EOS-AX6965 | BMS 599626 dihydrochloride | C27H27FN8O3.2HCl | 603.48 | CC(C(/N=C(OC[C@]1([H])COCCN1)\O)=CN2NC=N/3)=C2C3=N\C4=CC=C5C(C=NN5CC6=CC(F)=CC=C6)=C4.Cl.Cl | |
| EOS-AX6966 | GMQ hydrochloride | 5361-15-9 | C10H11N5.HCl | 237.69 | CC1=NC(NC(N)=N)=NC2=CC=CC=C12.Cl |
| EOS-AX6967 | 1,9-Dideoxyforskolin | 64657-18-7 | C22H34O5 | 378.5 | C=C[C@@](CC([C@]1([H])[C@]2(CCCC(C)([C@]2([H])[C@@](O)([H])[C@@](OC(C)=O)([H])[C@]13C)C)C)=O)(O3)C |
| EOS-AX6968 | PAOPA | 114200-31-6 | C11H18N4O3 | 254.29 | N=C(O)CN1CC[C@](/N=C(O)/[C@]2([H])CCCN2)([H])C1=O |
| EOS-AX6969 | Psalmotoxin 1 | C200H312N62O57S6 | 4689.41 | CCC(C(/N=C(O)\C(/N=C(O)/C(/N=C(O)/C(N)CCC(O)=O)CC(O)=O)CSSCC1C(O)=NC(C(O)=NCC(O)=NC(C(O)=NC(C(O)=NC(/C(O)=N/C(/C(O)=N/C(/C(O)=N/C(/C(O)=N/C(/C(O)=N/C(/C(O)=N\C(/C(O)=N/C(/C(O)=N/C(/C(O)=N/C(/C(O)=N/2)C(C)C)CCC(O)=O)CC3=CC=CC=C3)CO)CCCNC(N)=N)CCCNC(N)=N)CC | |
| EOS-AX6970 | PRT 4165 | 31083-55-3 | C15H9NO2 | 235.24 | O=C1C2=CC=CC=C2C(/C1=C/C3=CC=CN=C3)=O |
| EOS-AX6971 | TC-E 5001 | 865565-29-3 | C20H19N5O3S | 409.46 | CC(N1C(C=C2)=CC=C2OC)=NN=C1SCC3=NC(C(C=C4)=CC=C4OC)=NO3 |
| EOS-AX6972 | Qc 1 | 403718-45-6 | C23H16F3N3O2S | 455.45 | S=C(N=C1[C@@H]2C=CC(C(NCC3=CC=CC=C3)=O)=C1)N(C4=CC=CC(C(F)(F)F)=C4)C2=O |
| EOS-AX6973 | Cyclotraxin B | 1203586-72-4 | C48H73N13O17S3 | 1200.36 | C[C@](O)([H])[C@@](/N=C(O)/[C@](/N=C(O)/C/N=C(O)/[C@](/N=C(O)\[C@]1([H])CCCN12)([H])CCSC)([H])CC3=CC=C(O)C=C3)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/C/C(O)=N/[C@@](C(O)=O)([H])CSSC[C@@](N)([H])/C(O)=N/[C@@](C2=O)([H])CC(O)=N)([H])CCC(O)=O)([H])CCCCN |
| EOS-AX6974 | ICA 121431 | 313254-51-2 | C23H19N3O3S2 | 449.55 | O=C(NC1=CC=C(S(NC2=NC=CS2)(=O)=O)C=C1)C(C3=CC=CC=C3)C4=CC=CC=C4 |
| EOS-AX6975 | ANQ 11125 | 153966-48-4 | C86H125N19O21 | 1761.05 | CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CC1=CC=CC=C1)([H])C(C)C)([H])CC2=CC=CC=C2)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CC |
| EOS-AX6976 | J 147 | 1146963-51-0 | C18H17F3N2O2 | 350.33 | FC(F)(C(N(C1=CC=C(C)C=C1C)/N=C\C2=CC=CC(OC)=C2)=O)F |
| EOS-AX6977 | LDN 212320 | 894002-50-7 | C17H15N3S | 293.39 | CC1=CC=CC=C1CSC2=NN=C(C3=CC=CC=N3)C=C2 |
| EOS-AX6978 | L 012 sodium salt | 143556-24-5 | C13H8CIN4NaO2 | 310.67 | ClC1=NC(C2=CC=CC=C2)=C(N)C3=C1C(O)=NN=C3[O-].[Na+] |
| EOS-AX6979 | PG 931 | 667430-81-1 | C59H85N15O11 | 1180.41 | CCCCC(/N=C(O)/C)([H])/C(O)=N/[C@@](C1=O)([H])C/C(O)=N\CCCC[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)\[C@]2([H])CCCN21)([H])CC3=CC=CC=C3)([H])CCCNC(N)=N)([H])CC4=CNC5=CC=CC=C45)([H])C(N6CCC[C@@]6([H])/C(O)=N/[C@@](C(O)=N)([H])C(C)C)=O |
| EOS-AX6980 | OXA (17-33) | 343268-91-7 | C79H125N23O22 | 1749 | |
| EOS-AX6981 | iMDK | 881970-80-5 | C21H13FN2O2S | 376.4 | FC1=CC=C(CC(S2)=CN(C2=N3)C=C3C4=CC5=CC=CC=C5OC4=O)C=C1 |
| EOS-AX6982 | CTCE 9908 | 1030384-98-5 | C86H147N27O23 | 1927.27 | |
| EOS-AX6983 | Ononetin | 487-49-0 | C15H14O4 | 258.27 | O=C(C(C(O)=C1)=CC=C1O)CC(C=C2)=CC=C2OC |
| EOS-AX6984 | Ivermectin B1a-d2 | C48H72D2O14 | 877.1 | CCC(C1C(C)CCC2(CC3CC(C/C=C(C)/C(OC4CC(OC)C(OC5CC(OC)C(O)C(C)O5)C(C)O4)C(C)/C=C/C=C6COC7C\6(O)C(C(O3)=O)C=C(C)C7O)O2)O1)C | |
| EOS-AX6985 | DMNPE-caged ATP diammonium salt | C20H27N6O17P3.2NH3 | 750.44 | CC(OP(O)(OP(O)(OP(O)(OC[C@@](O1)([H])[C@@](O)([H])[C@@](O)([H])[C@@]1([H])N2C=NC(C2=NC=N3)=C3N)=O)=O)=O)([H])C4=CC(OC)=C(OC)C=C4N(=O)=O.N.N | |
| EOS-AX6986 | Morphine hydrochloride | 52-26-6 | C17H19NO3.HCl | 321.8 | |
| EOS-AX6987 | LY2584702 | 1082949-67-4 | C21H19F4N7 | 445.42 | CN(C(C1CCN(C2=NC=NC3=NNC=C32)CC1)=N4)C=C4C5=CC(C(F)(F)F)=C(F)C=C5 |
| EOS-AX6988 | PLX647 | 873786-09-5 | C21H17F3N4 | 382.38 | FC(F)(F)C1=CC=C(C/N=C2C=CC(CC3=CNC4=C3C=CC=N4)=CN\2)C=C1 |
| EOS-AX6989 | GDC-0994 | 1453848-26-4 | C21H18ClFN6O2 | 440.86 | CN1C(NC2=NC=CC(C(C=CN3[C@](C4=CC(F)=C(Cl)C=C4)([H])CO)=CC3=O)=N2)=CC=N1 |
| EOS-AX6990 | GSK2838232 | 1443461-21-9 | C48H73ClN2O6 | 809.56 | CC(C(C(C[C@@]([C@](O)([H])CN(CC1=CC=C(Cl)C=C1)CCN(C)C)2CC[C@]34C)=O)=C2[C@@]3([H])CC[C@]5([H])[C@]6(CC[C@@](OC(CC(C)(C(O)=O)C)=O)([H])C(C)(C6([H])CC[C@]54C)C)C)C |
| EOS-AX6991 | NMS-P715 | 1202055-34-2 | C35H39F3N8O3 | 676.73 | CCC1=C(/N=C(O)/C(C2=C3C4=NC(NC5=C(OC(F)(F)F)C=C(/C(O)=N/C(CC6)CCN6C)C=C5)=NC=C4CC2)=NN3C)C(CC)=CC=C1 |
| EOS-AX6992 | RO5126766(CH5126766) | 946128-88-7 | C21H18FN5O5S | 471.46 | CC(C1=C(O2)C=C(OC3=NC=CC=N3)C=C1)=C(C2=O)CC4=C(F)C(NS(NC)(=O)=O)=NC=C4 |
| EOS-AX6993 | CNX1351 | 1276105-89-5 | C30H35N7O3S | 573.71 | C/C(C)=C\C(CCC(N1CCN(CC(S2)=CC3=C2C(N4CCOCC4)=NC(C5=C6C=NNC6=CC=C5)=N3)CC1)=O)=O |
| EOS-AX6994 | TMC647055 | 1204416-97-6 | C32H38N4O6S | 606.73 | CN(C(C(CN1C2=C(C(C3CCCCC3)=C41)C=CC(/C(O)=N/S5(=O)=O)=C2)=CC6=C4C=CC(OC)=C6)=O)CCOCCN5C |
| EOS-AX6995 | LP533401 hcl | 1040526-12-2 | C27H23ClF4N4O3 | 562.94 | FC1=CC=CC(C2=CC=C(C(OC(C=C(N3)C4=CC=C(C[C@@](N)([H])C(O)=O)C=C4)=NC3=N)([H])C(F)(F)F)C=C2)=C1.Cl |
| EOS-AX6996 | Talampanel(LY300164) | 161832-65-1 | C19H19N3O3 | 337.37 | C[C@]1([H])CC2=CC(OCO3)=C3C=C2C(C4=CC=C(N)C=C4)=NN1C(C)=O |
| EOS-AX6997 | Carminomycin | 50935-04-1;39472-31-6 | C26H27NO10 | 513.49 | C[C@@]1([H])[C@](O)([H])[C@](N)([H])C[C@@](O[C@@]2([H])C[C@@](C(C)=O)(O)CC(C2=C3O)=C(O)C4=C3C(C5=C(C4=O)C=CC=C5O)=O)([H])O1 |
| EOS-AX6998 | Poziotinib | 1092364-38-9 | C23H21Cl2FN4O3 | 491.34 | C=CC(N1CCC(OC2=C(OC)C=C3C(C(NC4=C(F)C(Cl)=C(Cl)C=C4)=NC=N3)=C2)CC1)=O |
| EOS-AX6999 | RX-3117 | 865838-26-2 | C10H12FN3O4 | 257.22 | FC([C@](N(C(O)=N1)C=CC1=N)([H])[C@@](O)([H])[C@]2([H])O)=C2CO |
| EOS-AX7000 | Ximelagatran | 192939-46-1 | C24H35N5O5 | 473.57 | CCOC(CN[C@](C(N1CC[C@@]1([H])/C(O)=N/CC2=CC=C(/C(N)=N/O)C=C2)=O)([H])C3CCCCC3)=O |
| EOS-AX7001 | G007-LK | 1380672-07-0 | C25H16ClN7O3S | 529.96 | CS(C1=CN=C(C2=NN=C(N2C3=CC=CC=C3Cl)/C([H])=C([H])/C(O4)=NN=C4C5=CC=C(C#N)C=C5)C=C1)(=O)=O |
| EOS-AX7002 | Acalisib (GS-9820) | 870281-34-8 | C21H16FN7O | 401.4 | C[C@@](NC1=NC=NC2=C1N=CN2)([H])C(N3C4=CC=CC=C4)=NC5=C(C3=O)C=C(F)C=C5 |
| EOS-AX7003 | Altiratinib | 1345847-93-9 | C26H21F3N4O4 | 510.46 | FC1=CC=C(NC(C2(C(NC3=C(F)C=C(OC4=CC(NC(C5CC5)=O)=NC=C4)C(F)=C3)=O)CC2)=O)C=C1 |
| EOS-AX7004 | GSK503 | 1346572-63-1 | C31H38N6O2 | 526.67 | CC(N(C1=CC(C2=CN=C(N3CCN(CC3)C)C=C2)=CC(/C(O)=N/CC4=C(O)N=C(C=C4C)C)=C51)C=C5C)C |
| EOS-AX7005 | AMG837 | 865231-46-5 | C26H21F3O3 | 438.44 | CC#C[C@@](C1=CC=C(OCC2=CC(C3=CC=C(C(F)(F)F)C=C3)=CC=C2)C=C1)([H])CC(O)=O |
| EOS-AX7006 | AZD2932 | 883986-34-3 | C24H25N5O4 | 447.49 | CC(N1C=C(/N=C(O)/CC2=CC=C(OC3=NC=NC4=CC(OC)=C(OC)C=C43)C=C2)C=N1)C |
| EOS-AX7007 | AZ5104 | 1421373-98-9 | C27H31N7O2 | 485.58 | C=C/C(O)=N/C1=CC(NC2=NC=CC(C3=CNC4=CC=CC=C34)=N2)=C(OC)C=C1N(CCN(C)C)C |
| EOS-AX7008 | SAG | 912545-86-9 | C28H28ClN3OS | 490.06 | CN[C@@]1([H])CC[C@@](N(C(C2=C(Cl)C3=CC=CC=C3S2)=O)CC4=CC(C5=CC=NC=C5)=CC=C4)([H])CC1 |
| EOS-AX7009 | BX517(PDK1 inhibitor2) | 850717-64-5 | C15H14N4O2 | 282.3 | C/C(C1=CC=CN1)=C(C(O)=N2)\C3=C2C=CC(NC(O)=N)=C3 |
| EOS-AX7010 | SU6656 | 330161-87-0 | C19H21N3O3S | 371.45 | CN(S(C1=CC(/C(C(O)=N2)=C([H])/C(N3)=CC4=C3CCCC4)=C2C=C1)(=O)=O)C |
| EOS-AX7011 | SAR191801 | 1234708-04-3 | C22H20N6O3 | 416.43 | CC(C1=NC(C2=CC=CC(C/N=C(O)/C(C=N3)=CN=C3C4=CC=CC=N4)=C2)=NO1)(O)C |
| EOS-AX7012 | AMG-47A | 882663-88-9 | C29H28F3N5O2 | 535.56 | CC1=C(C(C=CC2=N/3)=CC2=CNC3=N/CCN4CCOCC4)C=C(/C(O)=N/C5=CC=CC(C(F)(F)F)=C5)C=C1 |
| EOS-AX7013 | FTI 277 HCl | 180977-34-8 | C22H30ClN3O3S2 | 484.07 | COC([C@](/N=C(O)/C1=C(C2=CC=CC=C2)C=C(NC[C@](N)([H])CS)C=C1)([H])CCSC)=O.Cl |
| EOS-AX7014 | CTX0294885 | 1439934-41-4 | C22H24ClN7O | 437.93 | C/N=C(O)/C1=CC=CC=C1/N=C(N2)\C(Cl)=CN=C2NC3=CC=C(N4CCNCC4)C=C3 |
| EOS-AX7015 | XMD-17-51 | C21H24N8O | 404.47 | CN(C1=CN=C(NC2=CN(C3CCNCC3)N=C2)N=C1N(C)C4=C5C=CC=C4)C5=O | |
| EOS-AX7016 | TH588 | 1609960-31-7 | C13H12Cl2N4 | 295.17 | ClC1=CC=CC(C(NC2=N)=C/C(N2)=N/C3CC3)=C1Cl |
| EOS-AX7017 | Radotinib(IY-5511) | 926037-48-1 | C27H21F3N8O | 530.5 | CC1=C(NC2=NC=CC(C3=CN=CC=N3)=N2)C=C(/C(O)=N/C4=CC(N(C=N5)C=C5C)=CC(C(F)(F)F)=C4)C=C1 |
| EOS-AX7018 | SNG-1153 | C21H17F3O5 | 406.35 | OC1=CC(O)=C(C/C=C(C)\C)C2=C1C(C(O)=C(C3=CC=C(C(F)(F)F)C=C3)O2)=O | |
| EOS-AX7019 | KNK437 | 218924-25-5 | C13H11NO4 | 245.23 | O=CN1/C(CCC1=O)=C([H])/C2=CC3=C(OCO3)C=C2 |
| EOS-AX7020 | TH287 | 1609960-30-6 | C11H10Cl2N4 | 269.13 | ClC1=C(Cl)C(C2=CC(NC)=NC(N)=N2)=CC=C1 |
| EOS-AX7021 | GS967 | 1262618-39-2 | C14H7F6N3O | 347.22 | FC(F)(F)C1=NN=C2C=CC(C3=CC=C(OC(F)(F)F)C=C3)=CN21 |
| EOS-AX7022 | FG2216 | 223387-75-5 | C12H9ClN2O4 | 280.66 | ClC1=NC(/C(O)=N/CC(O)=O)=C(O)C2=CC=CC=C21 |
| EOS-AX7023 | Mutant IDH1-IN-1 | 1355326-21-4 | C30H31FN4O2 | 498.59 | CC1=CC=CC=C1C(N(C(CN2C=NC3=CC=CC=C32)=O)C4=CC=CC(F)=C4)/C(O)=N/C5CCCCC5 |
| EOS-AX7024 | MHY1485 | 326914-06-1 | C17H21N7O4 | 387.39 | [O-][N+](C1=CC=C(NC2=NC(N3CCOCC3)=NC(N4CCOCC4)=N2)C=C1)=O |
| EOS-AX7025 | Pexidartinib (PLX3397) | 1029044-16-3 | C20H15ClF3N5 | 417.81 | ClC(C=N1)=CC2=C1NC=C2CC3=CN=C(NCC4=CN=C(C(F)(F)F)C=C4)C=C3 |
| EOS-AX7026 | P005672 hydrochloride | 1035979-44-2 | C24H30ClN3O8 | 523.96 | CN([C@@]1([H])[C@]2([H])C[C@](C3=C(O)[C@]2(O)C(C(C(O)=N)=C1O)=O)([H])CC4=C(CN(OC)C)C=CC(O)=C4C3=O)C.Cl |
| EOS-AX7027 | GSK1349572 sodiuM salt | 1051375-19-9 | C20H18F2N3NaO5 | 441.36 | C[C@](N12)([H])CCO[C@@]1([H])CN(C(C2=O)=C3[O-])C=C(/C(O)=N/CC4=C(F)C=C(F)C=C4)C3=O.[Na+] |
| EOS-AX7028 | SBE 13 HCl | 1052532-15-6 | C24H28Cl2N2O4 | 479.4 | COC1=C(OC)C=C(CCNCC2=CC(OC)=C(OCC3=CN=C(Cl)C=C3)C=C2)C=C1.Cl |
| EOS-AX7029 | ITD 1 | 1099644-42-4 | C29H32N6O4S | 560.67 | CC(C)(C1=C/C(NO1)=N/C(NC2=CC=C(C3=CN(C4=N3)C5=C(S4)C=C(OCCN6CCOCC6)C=C5)C=C2)=O)C |
| EOS-AX7030 | Entrectinib | 1108743-60-7 | C31H34F2N6O2 | 560.64 | CN1CCN(C2=CC(NC3CCOCC3)=C(C(/N=C4C5=C(NN/4)C=CC(CC6=CC(F)=CC(F)=C6)=C5)=O)C=C2)CC1 |
| EOS-AX7031 | TAK960 | 1137868-52-0 | C27H34F3N7O3 | 561.6 | CN1CCC(NC(C2=CC(OC)=C(NC3=NC=C(N(C(C(F)(F)CN4C5CCCC5)=O)C)C4=N3)C=C2F)=O)CC1 |
| EOS-AX7032 | Molidustat (BAY85-3934) | 1154028-82-6 | C13H14N8O2 | 314.3 | O=C1C(N2C=CN=N2)=CNN1C3=NC=NC(N4CCOCC4)=C3 |
| EOS-AX7033 | BMS-817378 | 1174161-69-3 | C24H18ClF2N4O7P | 578.85 | ClC1=C(OC2=C(F)C=C(/N=C(O)/C3=CN(COP(O)(O)=O)C=C(C3=O)C4=CC=C(F)C=C4)C=C2)C=CNC1=N |
| EOS-AX7034 | LX7101 HCL | 1192189-69-7 | C23H30ClN7O3 | 487.98 | CC1=CNC2=NC=NC(N3CCC(C(NC4=CC(OC(N(C)C)=O)=CC=C4)=O)(CN)CC3)=C21.Cl |
| EOS-AX7035 | Fruquintinib(HMPL-013) | 1194506-26-7 | C21H19N3O5 | 393.39 | CC(O1)=C(/C(O)=N/C)C2=C1C=C(OC3=NC=NC4=CC(OC)=C(OC)C=C43)C=C2 |
| EOS-AX7036 | 1,2-Dioleoyl-sn-glycerol | 24529-88-2 | C39H72O5 | 620.99 | O=C(CCCCCCC/C=C\CCCCCCCC)OC[C@H](CO)OC(CCCCCCC/C=C\CCCCCCCC)=O |
| EOS-AX7037 | SCH772984 HCl | C33H34ClN9O2 | 624.17 | O=C(N1CCN(C2=CC=C(C3=NC=CC=N3)C=C2)CC1)CN4CC[C@@](/C(O)=N/C5=CC(C(C6=CC=NC=C6)=NN7)=C7C=C5)([H])C4.Cl | |
| EOS-AX7038 | SCH772984 TFA | C35H34F3N9O4 | 701.7 | O=C([C@@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(C7=CC=NC=C7)NN=C6C=C5.FC(F)(C(O)=O)F | |
| EOS-AX7039 | MK3102 | 1226781-44-7 | C17H20F2N4O3S | 398.43 | CS(N1C=C2CN([C@](CO3)([H])C[C@@](N)([H])[C@@]3([H])C4=C(F)C=CC(F)=C4)CC2=N1)(=O)=O |
| EOS-AX7040 | ELR510444 | 1233948-35-0 | C19H16N2O2S2 | 368.47 | CC1=CC=C(S(NC2=C(C=CC(C3=CC=C(S3)C#N)=C2)C)(=O)=O)C=C1 |
| EOS-AX7041 | RQ-00203078 | 1254205-52-1 | C21H13ClF6N2O5S | 554.85 | ClC1=C(N(CC2=CC=C(OC(F)(F)F)C=C2)S(C3=CC=C(C(O)=O)C=C3)(=O)=O)N=CC(C(F)(F)F)=C1 |
| EOS-AX7042 | Spautin-1 | 1262888-28-7 | C15H11F2N3 | 271.26 | FC1=CC=C(C/N=C2C3=C(N=CN/2)C=CC(F)=C3)C=C1 |
| EOS-AX7043 | E3330 | 136164-66-4 | C21H30O6 | 378.46 | CCCCCCCCC/C(C(O)=O)=C([H])\C(C1=O)=C(C(C(OC)=C1OC)=O)C |
| EOS-AX7044 | GSK2879552 | 1401966-69-5 | C23H28N2O2 | 364.48 | OC(C1=CC=C(CN2CCC(CN[C@]3([H])C[C@@]3([H])C4=CC=CC=C4)CC2)C=C1)=O |
| EOS-AX7045 | CCT244747 | 1404095-34-6 | C20H24N8O2 | 408.46 | C[C@](OC1=NC(NC(C=C2OC)=NC=C2C(C=N3)=CN3C)=CN=C1C#N)([H])CN(C)C |
| EOS-AX7046 | RI-2 | 1417162-36-7 | C21H18Cl2N2O4 | 433.28 | COC1=CC=C(C(C(N2C3=CC(Cl)=C(Cl)C=C3)=O)=C(N4CCOCC4)C2=O)C=C1 |
| EOS-AX7047 | ORY-1001 | 1431326-61-2 | C15H24Cl2N2 | 303.27 | NC(CC1)CCC1N[C@H]2[C@H](C3=CC=CC=C3)C2 |
| EOS-AX7048 | PU-WS13 | 1454619-14-7 | C17H20Cl2N6S | 411.35 | CC(NCCCN1C2=NC=NC(N)=C2N=C1SC3=CC(Cl)=CC(Cl)=C3)C |
| EOS-AX7049 | BET bromodomain inhibitor | 1380087-89-7 | C20H16ClN3O2 | 365.81 | CC1=NOC2=C1C3=CC=CC=C3C(C4=CC=C(Cl)C=C4)=N[C@@]2([H])CC(O)=N |
| EOS-AX7050 | Retigabine | 150812-12-7 | C16H18FN3O2 | 303.33 | CCO/C(O)=N/C1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1 |
| EOS-AX7051 | EGF816 | 1508250-71-2 | C26H31ClN6O2 | 495.02 | CC1=CC(C(NC2=NC3=CC=CC(Cl)=C3N2[C@]4([H])CCCCN(C(/C([H])=C([H])/CN(C)C)=O)C4)=O)=CC=N1 |
| EOS-AX7052 | SEP-0372814 | 1516895-53-6 | C21H21N7 | 371.44 | CC1=C2N(N=C([C@@H]3[C@@H](C4=C(C)[N]5=C(C(C=CC=N6)=C6C=C5)=N4)C3)N2)C(C)C=N1 |
| EOS-AX7053 | Nolatrexed (AG-337) | 152946-68-4 | C14H14Cl2N4OS | 357.26 | CC1=C(SC2=CC=NC=C2)C(C(O)=NC3=N)=C(N3)C=C1.Cl.Cl |
| EOS-AX7054 | Rostafuroxin (PST 2238) | 156722-18-8 | C23H34O4 | 374.51 | C[C@]12CC[C@@](O)([H])C[C@@]1([H])CC[C@]3([H])[C@]2([H])CC[C@@]4([C@](C5=COC=C5)(O)CC[C@]34O)C |
| EOS-AX7055 | CARIPORIDE | 159138-80-4 | C12H17N3O3S | 283.35 | CC(C1=C(S(C)(=O)=O)C=C(/C(O)=N/C(N)=N)C=C1)C |
| EOS-AX7056 | VRT-1353385 | 1616113-45-1 | C35H39NO11 | 649.68 | CC(N1CCC2(C3=C(C4=C2C=C(C#C[C@](O5)([H])[C@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@]5([H])CO)C=C4)C=CC(C#C[C@](O6)([H])[C@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@]6([H])CO)=C3)CC1)=O |
| EOS-AX7057 | ML352 | 1649450-12-3 | C21H29N3O4 | 387.47 | CC(C1=NOC(C/N=C(O)/C2=CC(OC(CC3)CCN3C)=C(OC)C=C2)=C1)C |
| EOS-AX7058 | K-7174 | 191089-60-8 | C33H50Cl2N2O6 | 641.67 | COC1=C(OC)C(OC)=CC(/C([H])=C([H])/CCCN(CC2)CCCN2CCC/C([H])=C([H])/C3=CC(OC)=C(OC)C(OC)=C3)=C1.Cl.Cl |
| EOS-AX7059 | CL-387785 (EKI-785) | 194423-06-8 | C18H13BrN4O | 381.23 | CC#CC(NC1=CC(C(NC2=CC=CC(Br)=C2)=NC=N3)=C3C=C1)=O |
| EOS-AX7060 | LED209 | 245342-14-7 | C19H17N3O2S2 | 383.49 | O=S(C1=CC=C(N/C(S)=N/C2=CC=CC=C2)C=C1)(NC3=CC=CC=C3)=O |
| EOS-AX7061 | Regadenoson | 313348-27-5 | C15H18N8O5 | 390.35 | C/N=C(O)/C(C=N1)=CN1C2=NC(N)=C(N=CN3[C@@]4([H])[C@@](O)([H])[C@@](O)([H])[C@@](O4)([H])CO)C3=N2 |
| EOS-AX7062 | Tiplaxtinin(PAI-039) | 393105-53-8 | C24H16F3NO4 | 439.38 | FC(F)(OC1=CC=C(C2=CC(C(C(C(O)=O)=O)=CN3CC4=CC=CC=C4)=C3C=C2)C=C1)F |
| EOS-AX7063 | SBC-115076 | 489415-96-5 | C31H33N3O5 | 527.61 | CC1=CC(C(C(C(N2CCCN3CCOCC3)C4=CC=NC=C4)=C(O)C2=O)=O)=CC=C1OCC5=CC=CC=C5 |
| EOS-AX7064 | Rolapitant | 552292-08-7 | C25H26F6N2O2 | 500.48 | C[C@](OC[C@@]1(C2=CC=CC=C2)CC[C@@]3(CN1)CCC(O)=N3)([H])C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4 |
| EOS-AX7065 | Enocitabine | 55726-47-1 | C31H55N3O6 | 565.41 | CCCCCCCCCCCCCCCCCCCCCC(/N=C1C=CN(C(O)=N\1)[C@@]2([H])[C@](O)([H])[C@@](O)([H])[C@@](O2)([H])CO)=O |
| EOS-AX7066 | Chlorotrianisene | 569-57-3 | C23H21ClO3 | 380.86 | COC1=CC=C(/C(C2=CC=C(OC)C=C2)=C(Cl)/C3=CC=C(OC)C=C3)C=C1 |
| EOS-AX7067 | C7280948 | 587850-67-7 | C14H16N2O2S | 276.35 | NC1=CC=C(S(NCCC2=CC=CC=C2)(=O)=O)C=C1 |
| EOS-AX7068 | Cyclosporin D | 63775-96-2 | C63H111N11O12 | 1214.62 | C/C([H])=C([H])/C[C@@](C([C@@](N1C)([H])/C(O)=N\[C@@](C(N(CC(N([C@@](/C(O)=N/[C@@](C(N([C@@](/C(O)=N/[C@@](/C(O)=N/[C@](C(N([C@@](C(N([C@@](C(N([C@@](C1=O)([H])C(C)C)C)=O)([H])CC(C)C)C)=O)([H])CC(C)C)C)=O)([H])C)([H])C)([H])CC(C)C)C)=O)([H])C(C)C)([H])CC( |
| EOS-AX7069 | Chidamide | 743420-02-2 | C22H19FN4O2 | 390.41 | FC1=CC(NC(C2=CC=C(C/N=C(O)/C([H])=C([H])/C3=CN=CC=C3)C=C2)=O)=C(N)C=C1 |
| EOS-AX7070 | Solithromycin | 760981-83-7 | C43H65FN6O10 | 845.01 | CC[C@](O1)([H])[C@@]2([C@@](N(C(O2)=O)CCCCN3C=C(N=N3)C4=CC(N)=CC=C4)([H])[C@@](C([C@](C[C@@]([C@@](O[C@]5([H])[C@@](O)([H])[C@](N(C)C)([H])C[C@@](O5)([H])C)([H])[C@](C([C@@](C1=O)(F)C)=O)([H])C)(OC)C)([H])C)=O)([H])C)C |
| EOS-AX7071 | GS7340 | 379270-38-9/379270-37-8 | C25H33N6O9P | 592.54 | CC(OC([C@](NP(COC(CN1C=NC(C1=NC=N2)=C2N)([H])C)(OC3=CC=CC=C3)=O)([H])C)=O)C.O=C(O)/C([H])=C([H])/C(O)=O |
| EOS-AX7072 | |||||
| EOS-AX7073 | Cyclosporin H | 83602-39-5 | C62H111N11O12 | 1202.61 | C/C([H])=C([H])/C[C@@]([C@](O)([H])[C@@](N1C)([H])/C(O)=N\[C@@](C(N(CC(N([C@@](/C(O)=N/[C@@](C(N([C@@](/C(O)=N/[C@@](/C(O)=N/[C@](C(N([C@@](C(N([C@@](C(N([C@](C1=O)([H])C(C)C)C)=O)([H])CC(C)C)C)=O)([H])CC(C)C)C)=O)([H])C)([H])C)([H])CC(C)C)C)=O)([H])C(C)C |
| EOS-AX7074 | Cevipabulin | 849550-05-6 | C18H18ClF5N6O | 464.82 | C[C@@](NC1=C(C(Cl)=NC2=NC=NN12)C3=C(F)C=C(OCCCNC)C=C3F)([H])C(F)(F)F |
| EOS-AX7075 | TP-808 | 852821-06-8 | C26H34N2O5Si | 482.64 | CC(C)([Si](C)(O[C@@]12[C@@]([C@@](N(C)C)([H])C3=C(C(OCC4=CC=CC=C4)=NO3)C2=O)([H])CC=CC1=O)C)C |
| EOS-AX7076 | PF-3274167 | 900510-03-4 | C19H19ClFN5O3 | 419.84 | COCC(N1C2=CN=C(OC)C=C2)=NN=C1N3CC(OC4=C(Cl)C=C(F)C=C4)C3 |
| EOS-AX7077 | ELN441958 | 913064-47-8 | C29H29ClN4O2 | 501.02 | ClC1=CC=CC(CN2C3=CC=CC(C(N4CCC5(CC4)CCN(C6=CC=NC=C6)CC5)=O)=C3)=C1C2=O |
| EOS-AX7078 | AZD-5597 | 924641-59-8 | C23H28FN7O | 437.51 | CC(N1C(C)=NC=C1C2=NC(NC3=CC=C(C(N4CC[C@@](NC)([H])C4)=O)C=C3)=NC=C2F)C |
| EOS-AX7079 | GSK1014802(CNV1014802) | 934240-30-9 | C18H19FN2O2 | 314.35 | FC1=CC=CC=C1COC2=CC=C([C@@](N3)([H])CC[C@@]3([H])C(O)=N)C=C2 |
| EOS-AX7080 | INCB032304 | 941685-27-4 | C15H21N5OSi | 315.15 | C[Si](C)(CCOCN1C=CC(C1=NC=N2)=C2C3=CNN=C3)C |
| EOS-AX7081 | Decernotinib(VX-509) | 944842-54-0 | C18H19F3N6O | 392.38 | CC[C@](/C(O)=N/CC(F)(F)F)(NC1=NC(C2=CNC3=C2C=CC=N3)=NC=C1)C |
| EOS-AX7082 | mavatrep | 956274-94-5 | C25H21F3N2O | 422.44 | CC(C1=CC=CC=C1C2=CC(N3)=C(N=C3/C([H])=C([H])/C4=CC=C(C(F)(F)F)C=C4)C=C2)(O)C |
| EOS-AX7083 | TRX818 | 1256037-58-7 | C16H11FNNa2O5P | 393.21 | COC1=C(P([O-])([O-])=O)C(C(C=C2C3=CC(F)=CC=C3)=O)=C(N2)C=C1.[Na+].[Na+] |
| EOS-AX7084 | TBA354 | 1257426-19-9 | C19H15F3N4O5 | 436.34 | FC(F)(OC1=CC=C(C2=NC=C(CO[C@@]3([H])CN4C=C(N(=O)=O)N=C4OC3)C=C2)C=C1)F |
| EOS-AX7085 | ACY-241 | 1316215-12-9 | C24H26ClN5O3 | 467.95 | ClC1=CC=CC=C1N(C2=NC=C(/C(O)=N/CCCCCC/C(O)=N/O)C=N2)C3=CC=CC=C3 |
| EOS-AX7086 | KPT-9274 | 1643913-93-2 | C35H29F3N4O3 | 610.62 | FC1=CC=C(C2=CC(C3=CC=C(C(N4CCC(F)(F)CC4)=O)C=C3)=CC5=C2OC(C/N=C(O)/C([H])=C([H])/C6=NC(N)=CC=C6)=C5)C=C1 |
| EOS-AX7087 | TP-0903 | 1341200-45-0 | C24H30ClN7O2S | 516.06 | CN(S(C1=CC=CC=C1/N=C(N2)\C(Cl)=CN=C2NC3=CC=C(CN4CCN(CC4)C)C=C3)(=O)=O)C |
| EOS-AX7088 | ONO-4059 | 1351635-67-0 | C25H24N6O3 | 456.5 | NC1=C(N(C(N2[C@@H]3CN(C(C=C)=O)CCC3)=O)C(C=C4)=CC=C4OC5=CC=CC=C5)C2=NC=N1 |
| EOS-AX7089 | AS601245 | 345987-15-7 | C20H16N6S | 372.45 | N#CC(C1=NC2=CC=CC=C2S1)C(C=CN/3)=NC3=N/CCC4=CN=CC=C4 |
| EOS-AX7090 | Nitrotetrazolium Blue chloride | 298-83-9 | C40H30N10O6 • 2Cl | 817.63 | COC1=C([N+]2=NC(C3=CC=CC=C3)=NN2C4=CC=C([N+]([O-])=O)C=C4)C=CC(C5=CC(OC)=C([N+]6=NC(C7=CC=CC=C7)=NN6C8=CC=C([N+]([O-])=O)C=C8)C=C5)=C1 |
| EOS-AX7091 | Carteolol HCl | 51781-21-6 | C16H25ClN2O3 | 328.83 | CC(C)(NCC(O)COC1=CC=CC2=C1CCC(O)=N2)C.Cl |
| EOS-AX7092 | EW-7197 | 1352608-82-2 | C22H18FN7 | 399.42 | CC1=NC(C2=C(N=C(N2)CNC3=CC=CC=C3F)C(C=C4)=CN5C4=NC=N5)=CC=C1 |
| EOS-AX7093 | PF-4989216 | 1276553-09-3 | C18H13FN6OS | 380.4 | FC1=C(C(C(C#N)=C2N3CCOCC3)=C(S2)C4=NNC=N4)C=CC(C#N)=C1 |
| EOS-AX7094 | BG45 | 926259-99-6 | C11H10N4O | 214.22 | NC1=CC=CC=C1/N=C(O)/C2=CN=CC=N2 |
| EOS-AX7095 | AZD8186 | 1627494-13-6 | C24H25F2N3O4 | 457.47 | C[C@](NC1=CC(F)=CC(F)=C1)([H])C2=C3C(C(C=C(O3)N4CCOCC4)=O)=CC(C(N(C)C)=O)=C2 |
| EOS-AX7096 | AZD3839 | 1227163-84-9 | C24H16F3N5 | 431.41 | FC1=CC=CC([C@@]2(C3=CC(C(F)F)=NC=C3)C4=CC=CC(C5=CN=CN=C5)=C4)=C1C(N2)=N |
| EOS-AX7097 | LFM-A13 | 244240-24-2 | C11H8Br2N2O2 | 360 | C/C(O)=C(/C(O)=N/C1=C(Br)C=CC(Br)=C1)C#N |
| EOS-AX7098 | Dovitinib (TKI258) Lactate | 915769-50-5 | C24H29FN6O5 | 500.52 | FC1=C(C(N)=C(C2=O)C3=NC4=C(N3)C=C(N5CCN(C)CC5)C=C4)C(N2)=CC=C1.CC(O)C(O)=O.O |
| EOS-AX7099 | Dasatinib Monohydrate | 863127-77-9 | C22H28ClN7O3S | 506.02 | CC1=C(/N=C(O)/C(S2)=CN=C2NC3=CC(N4CCN(CCO)CC4)=NC(C)=N3)C(Cl)=CC=C1.O |
| EOS-AX7100 | Oltipraz | 64224-21-1 | C8H6N2S3 | 226.34 | CC(C1=S)=C(SS1)C2=CN=CC=N2 |
| EOS-AX7101 | GSK J4 free base | 1373423-53-0 | C24H27N5O2 | 417.46 | CCOC(CCNC1=CC(N2CCC3=CC=CC=C3CC2)=NC(C4=CC=CC=N4)=N1)=O |
| EOS-AX7102 | PF-03394197(Oclacitinib) | 1208319-26-9 | C15H23N5O2S | 337.44 | CNS(C[C@@]1([H])CC[C@@](N(C2=NC=NC3=C2C=CN3)C)([H])CC1)(=O)=O |
| EOS-AX7103 | Cytosporone B | 321661-62-5 | C18H26O5 | 322.4 | OC1=CC(O)=CC(CC(OCC)=O)=C1C(CCCCCCC)=O |
| EOS-AX7104 | AZD3759 | 1626387-80-1 | C22H23ClFN5O3 | 459.9 | ClC1=CC=CC(NC2=NC=NC3=CC(OC)=C(OC(N4[C@H](C)CN(C)CC4)=O)C=C23)=C1F |
| EOS-AX7105 | 7-Ethoxyresorufin | 5725-91-7 | C14H11NO3 | 241.24 | CCOC1=CC2=C(N=C3C=CC(C=C3O2)=O)C=C1 |
| EOS-AX7106 | MnTBAP Chloride | 55266-18-7 | C48H28ClMnN4O8 | 879.15 | O=C([O-])C1=CC=C(/C(C(C=C/2)=NC2=C3C4=CC=C(C(O)=O)C=C4)=C([N-]/5)/C=CC5=C(C(N6)=CC=C6/C(C7=CC=C(C(O)=O)C=C7)=C8C=CC/3=N\8)\C9=CC=C(C([O-])=O)C=C9)C=C1.Cl.[Mn+3] |
| EOS-AX7107 | Tamoxifen | 10540-29-1 | C26H29NO | 371.51 | CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(C)C)C=C2)\C3=CC=CC=C3 |
| EOS-AX7108 | Granzyme B Inhibitor Z-AAD-CH2Cl | C20H26ClN3O7 | 455.89 | CC(/N=C(O)/C(/N=C(OCC1=CC=CC=C1)\O)C)/C(O)=N/C(C(CCl)=O)CC(OC)=O | |
| EOS-AX7109 | UF 010 | 537672-41-6 | C11H15BrN2O | 271.15 | O=C(NNCCCC)C1=CC=C(Br)C=C1 |
| EOS-AX7110 | BML-210(CAY10433) | 537034-17-6 | C20H25N3O2 | 339.43 | NC1=CC=CC=C1/[*]=C(O)/CCCCCC/C(O)=N/C2=CC=CC=C2 |
| EOS-AX7111 | 2-hexyl-4-Pentynoic Acid | 96017-59-3 | C11H18O2 | 182.26 | CCCCCCC(C(O)=O)CC#C |
| EOS-AX7112 | Sanguinarine chloride | 5578-73-4 | C20H14ClNO4 | 367.78 | C[N+]1=C2C(C=CC3=CC(OCO4)=C4C=C32)=C5C=CC(OCO6)=C6C5=C1.[Cl-] |
| EOS-AX7113 | Triacetyl Resveratrol | 42206-94-0 | C20H18O6 | 354.35 | CC(OC1=CC=C(C=C1)/C([H])=C([H])/C2=CC(OC(C)=O)=CC(OC(C)=O)=C2)=O |
| EOS-AX7114 | 2,4-Pyridinedicarboxylic Acid | 499-80-9 | C7H5NO4 | 167.12 | O=C(O)C1=CC(C(O)=O)=NC=C1 |
| EOS-AX7115 | PFI 4 | 900305-37-5 | C21H24N4O3 | 380.44 | [H]N(C(C1=CC=CC=C1OC)=O)C2=C(N3CCCC3)C=C(N(C)C(N4C)=O)C4=C2 |
| EOS-AX7116 | O6-Benzylguanine | 19916-73-5 | C12H11N5O | 241.2 | [H]N1C2=NC(N)=NC(OCC3=CC=CC=C3)=C2N=C1 |
| EOS-AX7117 | Suberohydroxamic Acid | 38937-66-5 | C8H16N2O4 | 204.22 | ON([H])C(CCCCCCC(N(O)[H])=O)=O |
| EOS-AX7118 | Windorphen | 19881-70-0 | C17H15ClO3 | 302.75 | O=C/C(C1=CC=C(OC)C=C1)=C(Cl)\C2=CC=C(OC)C=C2 |
| EOS-AX7119 | BDA-366 | C24H29N3O4 | 423.5 | CCN(CC)C[C@@H](O)CNC1=CC=C(NC[C@@H]2OC2)C3=C1C(C4=C(C3=O)C=CC=C4)=O | |
| EOS-AX7120 | CCT251545 | 1661839-45-7 | C23H24ClN5O | 421.92 | O=C(NCC1)C1(CC2)CCN2C3=C(C4=CC=C(C5=CN(C)N=C5)C=C4)C=NC=C3Cl |
| EOS-AX7121 | CHZ868 | C22H19F2N5O2 | 423.42 | CN(C(NC1=CC=C(F)C=C1F)=N2)C(C2=C3C)=CC=C3OC4=CC=NC(NC(C)=O)=C4 | |
| EOS-AX7122 | DC_AC50 | 497061-48-0 | C17H12BrF2N3OS | 424.26 | NC1=C(C(NC2=C(C=C(F)C=C2Br)F)=O)SC3=NC4=C(CCC4)C=C31 |
| EOS-AX7123 | QX-314 | 24003-58-5 | C16H27BrN2O | 343.3 | CC1=CC=CC(C)=C1N([H])C(C[N+](CC)(CC)CC)=O.[Br-] |
| EOS-AX7124 | MN 64 | 92831-11-3 | C18H16O2 | 264.32 | CC(C1=CC=C(C2=CC(C3=CC=CC=C3O2)=O)C=C1)C |
| EOS-AX7125 | Naproxen Sodium | 26159-34-2 | C14H13NaO3 | 252.24 | C[C@@](C([O-])=O)([H])C1=CC2=CC=C(OC)C=C2C=C1.[Na+] |
| EOS-AX7126 | 3-Indolebutyric acid (IBA) | 133-32-4 | C12H13NO2 | 203.24 | O=C(O)CCCC1=CNC2=CC=CC=C12 |
| EOS-AX7127 | Enoxolone | 471-53-4 | C30H46O4 | 470.68 | CC([C@]1([H])CC[C@]23C)([C@](O)([H])CC[C@@]1([C@@]2([H])C(C=C4[C@]5([H])C[C@](CC[C@](CC[C@]43C)5C)(C(O)=O)C)=O)C)C |
| EOS-AX7128 | Sclareolide | 564-20-5 | C16H26O2 | 250.38 | CC(CCC[C@@]1([C@@]2([H])CC(O3)=O)C)([C@]1([H])CC[C@]23C)C |
| EOS-AX7129 | Troxerutin | 7085-55-4 | C33H42O19 | 742.68 | C[C@@](O1)([H])[C@@](O)([H])[C@](O)([H])[C@](O)([H])[C@]1([H])OC[C@]2([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@@](OC(C(C3=C(O)C=C(OCCO)C=C3O4)=O)=C4C5=CC(OCCO)=C(OCCO)C=C5)([H])O2 |
| EOS-AX7130 | Xanthone | 90-47-1 | C13H8O2 | 196.2 | O=C1C2=CC=CC=C2OC3=CC=CC=C31 |
| EOS-AX7131 | Diosmetin | 520-34-3 | C16H12O6 | 300.26 | COC1=C(O)C=C(C2=CC(C3=C(O)C=C(O)C=C3O2)=O)C=C1 |
| EOS-AX7132 | Lappaconite HBr | 97792-45-5 | C32H45BrN2O8 | 665.61 | CCN1C[C@]2(OC(C3=CC=CC=C3/N=C(O)/C)=O)CC[C@@](OC)([H])[C@@]4([C@]5([H])C[C@]6([H])[C@](OC)([H])C[C@@]7(O)[C@@]5(O)[C@@]6([H])OC)[C@]2([H])C[C@@]7([H])C41[H].Br |
| EOS-AX7133 | Astragaloside A | 83207-58-3 | C41H68O14 | 784.97 | CC1([C@](O[C@@]2([H])[C@@](O)([H])[C@](O)([H])[C@@](O)([H])CO2)([H])CC[C@]34C[C@@]([C@@]5([H])C[C@@](O[C@@]6([H])[C@@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O6)([H])CO)([H])[C@@]14[H])3CC[C@@]7([C@]([C@]8(CC[C@@](O8)([H])C(C)(O)C)C)([H])[C@](O)([H])C[C@@] |
| EOS-AX7134 | N6-methyladenosine (m6A) | 1867-73-8 | C11H15N5O4 | 281.27 | CNC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])CO)C2=NC=N1 |
| EOS-AX7135 | Cyclobenzaprine HCl | 6202-23-9 | C20H22ClN | 311.85 | CN(CC/C=C1C2=CC=CC=C2C=CC3=CC=CC=C3\1)C.Cl |
| EOS-AX7136 | Calcium D-Panthotenate | 137-08-6 | C18H32CaN2O10 | 476.53 | CC(CO)([C@](O)([H])/C([O-])=N/CCC([O-])=O)C.CC(CO)([C@](O)([H])/C(O)=N/CCC(O)=O)C.[Ca+2] |
| EOS-AX7137 | Motolimod (VTX-2337) | 926927-61-9 | C28H34N4O2 | 458.6 | CCCN(C(C(CC1=N)=CC2=C(N1)C=C(C3=CC=C(C(N4CCCC4)=O)C=C3)C=C2)=O)CCC |
| EOS-AX7138 | Dyngo-4a | 1256493-34-1 | C18H14N2O5 | 338.31 | O=C(C1=CC=C2C=CC=CC2=C1)N/N=C/C3=CC(O)=C(O)C(O)=C3O |
| EOS-AX7139 | GSK2801 | 1619994-68-1 | C20H21NO4S | 371.45 | CCCOC(C=CN12)=CC2=C(C3=CC=CC=C3S(C)(=O)=O)C=C1C(C)=O |
| EOS-AX7140 | FLLL32 | 1226895-15-3 | C28H32O6 | 464.55 | COC1=C(OC)C=C(/C([H])=C([H])/C(C2(C(/C([H])=C([H])/C3=CC(OC)=C(OC)C=C3)=O)CCCCC2)=O)C=C1 |
| EOS-AX7141 | 4-Methylumbelliferone (4-MU) | 90-33-5 | C10H8O3 | 176.17 | CC(C1=C(O2)C=C(O)C=C1)=CC2=O |
| EOS-AX7142 | K-Ras(G12C) inhibitor 9 | 1469337-91-4 | C16H21ClIN3O4S | 513.78 | C=CS(NC1CCN(C(CNC2=C(OC)C=C(Cl)C(I)=C2)=O)CC1)(=O)=O |
| EOS-AX7143 | SB273005 | 205678-31-5 | C22H24F3N3O4 | 451.44 | CNC1=CC=CC(CCOC(C=C2CN3CC(F)(F)F)=CC=C2C[C@@](C3=O)([H])CC(O)=O)=N1 |
| EOS-AX7144 | PX-478 2HCl | 685898-44-6 | C13H20Cl4N2O3 | 394.12 | ClCC[N+](C1=CC=C(C[C@@](N)([H])C(O)=O)C=C1)([O-])CCCl.Cl.Cl |
| EOS-AX7145 | Peficitinb (ASP015K, JNJ-54781532) | 944118-01-8 | C18H22N4O2 | 326.39 | N=C(O)C1=CNC2=NC=CC2=C1N[C@]3([H])[C@@](C4)([H])C[C@@]5([H])C[C@]3([H])C[C@]4(O)C5 |
| EOS-AX7146 | NPS-1034 | 1221713-92-3 | C31H23F2N5O3 | 551.54 | FC1=CC(NC(C2=C(C)N(C)N(C3=CC=C(F)C=C3)C2=O)=O)=CC=C1OC4=CC=NC5=C4C(C6=CC=CC=C6)=CN5 |
| EOS-AX7147 | AZD6738 | 1352226-88-0 | C20H24N6O2S | 412.51 | C[C@H]1N(C2=NC(C3=C4C(NC=C4)=NC=C3)=NC(C5([S@](=O)(C)=N)CC5)=C2)CCOC1 |
| EOS-AX7148 | BPTES | 314045-39-1 | C24H24N6O2S3 | 524.68 | O/C(CC1=CC=CC=C1)=N\C2=NN=C(S2)CCSCCC(S3)=NN=C3/N=C(O)/CC4=CC=CC=C4 |
| EOS-AX7149 | 6-Thio-dG | 789-61-7 | C10H13N5O3S | 283.31 | N=C1NC2=C(N=CN2[C@@]3([H])C[C@@](O)([H])[C@@](O3)([H])CO)C(S)=N1 |
| EOS-AX7150 | Coelenterazine | 55779-48-1 | C26H21N3O3 | 423.46 | OC1=CC=C(CC(C2=O)=NC3=C(NC(C4=CC=C(O)C=C4)=CN32)CC5=CC=CC=C5)C=C1 |
| EOS-AX7151 | A-1210477 | 1668553-26-1 | C46H55N7O7S | 850.04 | CC1=NN(C(COC2=CC=C(N3CCN(S(N(C)C)(=O)=O)CC3)C=C2)=C1C4=CC=CC(C(CCCOC5=CC=CC6=CC=CC=C65)=C7C(O)=O)=C4N7CCN8CCOCC8)C |
| EOS-AX7152 | Pexmetinib (ARRY-614) | 945614-12-0 | C31H33FN6O3 | 556.63 | CC1=CC=C(N2C(N/C(O)=N/CC3=CC(F)=CC=C3OC4=CC=C5C(C=NN5CCO)=C4)=CC(C(C)(C)C)=N2)C=C1 |
| EOS-AX7153 | AMG319 | 1608125-21-8 | C21H16FN7 | 385.4 | C[C@@](NC1=NC=NC2=C1N=CN2)([H])C(C=C3C=CC(F)=CC3=N4)=C4C5=CC=CC=N5 |
| EOS-AX7154 | BI-847325 | 1207293-36-4 | C29H28N4O2 | 464.56 | CCNC(C#CC1=CC=C2C(NC(/C2=C(NC3=CC=C(CN(C)C)C=C3)/C4=CC=CC=C4)=O)=C1)=O |
| EOS-AX7155 | Cyclo(RGDyK) | 250612-42-1 | C31H43F6N9O12 | 847.72 | NCCCC[C@@]1([H])/C(O)=N/[C@@](/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@](/C(O)=N/1)([H])CC2=CC=C(O)C=C2)([H])CC(O)=O)([H])CCCNC(N)=N.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O |
| EOS-AX7156 | SirReal2 | 709002-46-0 | C22H20N4OS2 | 420.55 | O=C(CSC1=NC(C)=CC(C)=N1)NC2=NC=C(S2)CC3=CC=CC4=CC=CC=C43 |
| EOS-AX7157 | AZD3264 | 1609281-86-8 | C21H23N5O4S | 441.5 | CC1=NOC(C)=C1C2=CC(O[C@H]3CCNC3)=C(C4=CC(C(N)=O)=C(NC(N)=O)S4)C=C2 |
| EOS-AX7158 | Disodium (R)-2-Hydroxyglutarate | 103404-90-6 | C5H6Na2O5 | 192.08 | O[C@](C([O-])=O)([H])CCC([O-])=O.[Na+].[Na+] |
| EOS-AX7159 | Sodium Tauroursodeoxycholate (TUDC) | 35807-85-3 | C26H44NNaO6S | 521.69 | C[C@]([C@@]1([H])CC[C@@]2([H])[C@@]([C@](O)([H])C[C@]3([H])C[C@@](O)([H])CC[C@@]34C)([H])[C@]4([H])CC[C@]12C)([H])CC/C([O-])=N/CCS(O)(=O)=O.[Na+] |
| EOS-AX7160 | GSK621 | 1346607-05-3 | C26H20ClN3O5 | 489.91 | COC1=CC=CC(C2=CC=C(N3C(Cl)=CC(NC(N4C5=CC=CC(OC)=C5)=O)=C3C4=O)C=C2)=C1O |
| EOS-AX7161 | Dp44mT | 152095-12-0 | C14H15N5S | 285.37 | CN(/C(S)=N/N=C(C1=CC=CC=N1)\C2=CC=CC=N2)C |
| EOS-AX7162 | Metoprolol Succinate | 98418-47-4 | C34H56N2O10 | 652.82 | OC(COC(C=C1)=CC=C1CCOC)CNC(C)C.OC(COC(C=C2)=CC=C2CCOC)CNC(C)C.OC(CCC(O)=O)=O |
| EOS-AX7163 | PD-1/PD-L1 inhibitor 2 | 1675203-84-5 | C25H29N3O3 | 419.52 | CC1=C(COC2=NC(OC)=C(CNCCNC(C)=O)C=C2)C=CC=C1C3=CC=CC=C3 |
| EOS-AX7164 | DEL-22379 | 181223-80-3 | C26H28N4O3 | 444.53 | O=C1NC2=CC=C(NC(CCN3CCCCC3)=O)C=C2C1=CC4=CNC5=CC=C(OC)C=C54 |
| EOS-AX7165 | DASA-58 | 1203494-49-8 | C19H23N3O6S2 | 453.53 | O=S(N1CCN(S(C2=CC(OCCO3)=C3C=C2)(=O)=O)CCC1)(C4=CC=CC(N)=C4)=O |
| EOS-AX7166 | VR23 | 1624602-30-7 | C19H16ClN5O6S | 477.88 | ClC1=CC2=C(C(N3CCN(S(C4=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C4)(=O)=O)CC3)=CC=N2)C=C1 |
| EOS-AX7167 | O4I2 | 165682-93-9 | C12H11ClN2O2S | 282.75 | CCOC(C1=CSC(NC2=CC=C(Cl)C=C2)=N1)=O |
| EOS-AX7168 | P7C3 | 301353-96-8 | C21H18Br2N2O | 474.19 | BrC1=CC(C2=C3C=CC(Br)=C2)=C(N3CC(O)CNC4=CC=CC=C4)C=C1 |
| EOS-AX7169 | Napabucasin | 83280-65-3 | C14H8O4 | 240.21 | CC(C(O1)=CC2=C1C(C3=CC=CC=C3C2=O)=O)=O |
| EOS-AX7170 | SKF38393 HCl | 62717-42-4 | C16H18ClNO2 | 291.77 | OC1=C(O)C=C2C(CCNCC2C3=CC=CC=C3)=C1.Cl |
| EOS-AX7171 | GMX1778 (CHS828) | 200484-11-3 | C19H22ClN5O | 371.86 | ClC1=CC=C(OCCCCCC/N=C(\N=C2C=CNC=C/2)NC#N)C=C1 |
| EOS-AX7172 | CB-5083 | 1542705-92-9 | C24H23N5O2 | 413.47 | CC1=CC2=C(C(O)=N)C=CC=C2N1C3=NC4=C(/C(N3)=N\CC5=CC=CC=C5)COCC4 |
| EOS-AX7173 | GNF-7 | 839706-07-9 | C28H24F3N7O2 | 547.53 | CC1=C(N(C2=O)CC(C(N2C)=N3)=CN=C3NC4=CN=C(C=C4)C)C=C(/N=C(O)/C5=CC(C(F)(F)F)=CC=C5)C=C1 |
| EOS-AX7174 | Filipin III | 480-49-9 | C35H58O11 | 654.83 | O[C@@H]1/C(C)=C/C=C/C=C/C=C/C=C/[C@H](O)[C@@H](C)OC([C@@]([C@H](O)CCCCC)([H])[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C1)=O |
| EOS-AX7175 | 2-NBDG | 186689-07-6 | C12H14N4O8 | 342.26 | OC[C@](O1)([H])[C@](O)([H])[C@@](O)([H])[C@](NC2=CC=C(N(=O)=O)C3=NON=C23)([H])C1([H])O |
| EOS-AX7176 | INCB-024360 | 1204669-58-8 | C11H13BrFN7O4S | 438.23 | BrC1=C(F)C=CC(/N=C(NO)\C2=NON=C2NCCNS(N)(=O)=O)=C1 |
| EOS-AX7177 | MnTMPyP Pentachloride | 125565-45-9 | C44H36Cl5MnN8 | 909.01 | CN1C=C/C(C=C1)=C(C(C=C/2)=NC2=C3C(C=C4)=CC=[N+]4C)\C(C=C/5)=NC5=C(C([N-]6)=CC=C6/C(C(C=C7)=CC=[N+]7C)=C8C=CC\3=N/8)\C(C=C9)=CC=[N+]9C.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3] |
| EOS-AX7178 | Ozanimod (RPC1063) | 1306760-87-1 | C23H24N4O3 | 404.46 | CC(OC1=C(C#N)C=C(C2=NC(C3=CC=CC4=C3CC[C@]4([H])NCCO)=NO2)C=C1)C |
| EOS-AX7179 | ARQ 621 | 1095253-39-6 | C28H24Cl2FN5O2 | 552.43 | C#CC[C@](N(C(C1=C(F)C(Cl)=CC=C1)=O)CCCN)([H])C(N2NC3=CC=CC=C3)=NC4=C(C2=O)C=CC(Cl)=C4 |
| EOS-AX7180 | D-Luciferin | 2591-17-5 | C11H8N2O3S2 | 280.32 | OC1=CC(S2)=C(N=C2C3=N[C@](C(O)=O)([H])CS3)C=C1 |
| EOS-AX7181 | EPI-001 | 227947-06-0 | C21H27ClO5 | 394.89 | CC(C1=CC=C(OCC(O)CCl)C=C1)(C2=CC=C(OCC(O)CO)C=C2)C |
| EOS-AX7182 | K03861 | 853299-07-7 | C24H26F3N7O2 | 501.5 | CN1CCN(CC2=C(C(F)(F)F)C=C(NC(NC3=CC=C(OC4=NC(N)=NC=C4)C=C3)=O)C=C2)CC1 |
| EOS-AX7183 | LJI308 | 1627709-94-7 | C21H18F2N2O2 | 368.38 | FC1=C(O)C(F)=CC(C(C=NC=C2)=C2C3=CC=C(N4CCOCC4)C=C3)=C1 |
| EOS-AX7184 | NCT-501 | 1802088-50-1 | C21H32N6O3 | 416.52 | CC(CCN1C(CN2CCN(C(C3CC3)=O)CC2)=NC(N(C4=O)C)=C1C(N4C)=O)C |
| EOS-AX7185 | NSC59984 | 803647-40-7 | C12H15N3O4 | 265.27 | CN1CCN(C(/C=C/C2=CC=C([N+]([O-])=O)O2)=O)CC1 |
| EOS-AX7186 | NVP-TNKS656 | 1419949-20-4 | C27H34N4O5 | 494.58 | COC1=CC=C(C(C2CCN(CC(N(CC3=NC4=C(C(O)=N3)COCC4)CC5CC5)=O)CC2)=O)C=C1 |
| EOS-AX7187 | O4I1 | 175135-47-4 | C16H15NO2 | 253.3 | COC1=CC=C(COC2=CC=C(CC#N)C=C2)C=C1 |
| EOS-AX7188 | SGC707 | 1687736-54-4 | C16H18N4O2 | 298.34 | O=C(NCC(N1CCCC1)=O)NC2=CC3=CC=NC=C3C=C2 |
| EOS-AX7189 | Tedizolid HCl | C17H16ClFN6O3 | 406.8 | FC1=CC(N2C[C@H](CO)OC2=O)=CC=C1C3=CC=C(C4=NN(C)N=N4)N=C3.Cl | |
| EOS-AX7190 | Phenyl sulfate | C6H6O4S | 174.17 | OS(OC1=CC=CC=C1)(=O)=O | |
| EOS-AX7191 | 4-ethylphenyl sulfate | C8H10O4S | 202.23 | OS(OC1=CC=C(CC)C=C1)(=O)=O | |
| EOS-AX7192 | Nitrocefin | 41906-86-9 | C21H16N4O8S2 | 516.5 | [H][C@]1([C@@H]2NC(CC3=CC=CS3)=O)SCC(/C=C/C4=CC=C([N+]([O-])=O)C=C4[N+]([O-])=O)=C(C(O)=O)N1C2=O |
| EOS-AX7193 | PalMitoyl Tripeptide-1 | 147732-56-7 | C30H54N6O5 | 578.79 | CCCCCCCCCCCCCCC/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CCCCN)([H])CC1=CN=CN1 |
| EOS-AX7194 | EAI045 | C19H14FN3O3S | 383.4 | FC1=CC(C(N2CC3=CC=CC=C3C2=O)/C(O)=N/C4=NC=CS4)=C(O)C=C1 | |
| EOS-AX7195 | TCEP hydrochloride | 51805-45-9 | C9H16ClO6P | 286.65 | O=C(O)CCP(CCC(O)=O)CCC(O)=O.Cl |
| EOS-AX7196 | A 779 | 159432-28-7 | C39H60N12O11 | 872.97 | CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CC(O)=O)([H])CCCNC(N)=N)([H])C(C)C)([H])CC1=CC=C(O)C=C1)([H])/C(O)=N/[C@@](/C(O)=N/[C@](C(O)=O)([H])C)([H])CC2=CN=CN2)([H])C |
| EOS-AX7197 | Amyloid β-Peptide (1-42) (human) | C203H311N55O60S | 4514.08 | ||
| EOS-AX7198 | (±)-Nutlin-3 | 548472-68-0 | C30H30Cl2N4O4 | 581.49 | ClC1=CC=C(C=C1)C2N(C(N(C3)CCNC3=O)=O)C(C(C=CC(OC)=C4)=C4OC(C)C)=NC2C(C=C5)=CC=C5Cl |
| EOS-AX7199 | Wnt agonist 1 | 853220-52-7 | C19H19ClN4O3 | 386.83 | COC1=CC=CC(C(NC2=N)=C/C(N2)=N/CC3=CC4=C(OCO4)C=C3)=C1.Cl |
| EOS-AX7200 | Pyridoxal isonicotinoyl hydrazone | 737-86-0 | C14H14N4O3 | 286.29 | CC1=C(O)C(/C([H])=N/NC(C2=CC=NC=C2)=O)=C(CO)C=N1 |
| EOS-AX7201 | Manumycin A | 52665-74-4 | C31H38N2O7 | 550.64 | CCCC[C@H](/C=C(/C=C(C(NC1=C[C@@](/C=C/C=C\C=C/C(NC2=C(CCC2=O)O)=O)([C@@H]3O[C@@H]3C1=O)O)=O)/C)C)C |
| EOS-AX7202 | SIRT1/2 Inhibitor IV | 14513-15-6 | C21H16N2O2S | 360.43 | OC(C=CC1=CC=CC=C12)=C2CC(C(O)=NC(S)=N3)=C3C4=CC=CC=C4 |
| EOS-AX7203 | Myriocin | 35891-70-4 | C21H39NO6 | 401.54 | CCCCCCC(CCCCCC/C([H])=C([H])/C[C@](O)([H])[C@@](O)([H])[C@@](C(O)=O)(N)CO)=O |
| EOS-AX7204 | Calcium Ionophore I | 58801-34-6 | C38H72N2O8 | 684.99 | C[C@H]([C@H](OCC(N(CCCCCCCCCCCC(OCC)=O)C)=O)C)OCC(N(C)CCCCCCCCCCCC(OCC)=O)=O |
| EOS-AX7205 | Bisindolylmaleimide V | 113963-68-1 | C21H15N3O2 | 341.36 | CN1C(C(C2=CNC3=CC=CC=C23)=C(C1=O)C4=CNC5=CC=CC=C45)=O |
| EOS-AX7206 | N-(p-amylcinnamoyl) Anthranilic Acid | 110683-10-8 | C21H23NO3 | 337.41 | CCCCCC1=CC=C(/C([H])=C([H])/C(O)=N/C2=CC=CC=C2C(O)=O)C=C1 |
| EOS-AX7207 | Deferoxamine mesylate | 138-14-7 | C26H52N6O11S | 656.79 | CC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCCN)=O)=O)=O.CS(O)(=O)=O |
| EOS-AX7208 | W 54011 | 405098-33-1 | C30H37ClN2O2 | 493.08 | CC(C1=CC=C(N(C(C2CCCC3=C2C=C(OC)C=C3)=O)CC4=CC=C(N(C)C)C=C4)C=C1)C.Cl |
| EOS-AX7209 | Spadin | 1270083-24-3 | C96H142N26O22 | 2012.32 | CC[C@]([C@@](/N=C(O)/[C@]1([H])CCCN1C(C/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@]2([H])CCCN2C([C@](/N=C(O)/[C@]3([H])CCCN3C([C@](/N=C(O)/[C@](N)([H])CC4=CC=C(O)C=C4)([H])C)=O)([H])CC(C)C)=O)([H])CCCNC(N)=N)([H])CC5=CNC6=CC=CC=C56)([H])CO)=O)([H]) |
| EOS-AX7210 | GW 610 | 872726-44-8 | C15H12FNO2S | 289.32 | FC1=CC2=C(SC(C3=CC=C(OC)C(OC)=C3)=N2)C=C1 |
| EOS-AX7211 | Sildenafil mesylate | 131543-23-2 | C23H34N6O7S2 | 570.68 | CCCC(C(N=C(N1)C2=C(OCC)C=CC(S(N3CCN(CC3)C)(=O)=O)=C2)=C4C1=O)=NN4C.CS(O)(=O)=O |
| EOS-AX7212 | Sulindac sulfide | 32004-67-4 | C20H17FO2S | 340.41 | FC1=CC2=C(/C(C(C)=C2CC(O)=O)=C\C3=CC=C(SC)C=C3)C=C1 |
| EOS-AX7213 | Monastrol | 254753-54-3 | C14H16N2O3S | 292.35 | CCOC(C(C1C2=CC(O)=CC=C2)=C(N=C(S)N1)C)=O |
| EOS-AX7214 | Myoseverin | 267402-71-1 | C24H28N6O2 | 432.52 | CC(N1C=NC(C1=N/C2=N/CC3=CC=C(OC)C=C3)=C(N2)NCC4=CC=C(OC)C=C4)C |
| EOS-AX7215 | E-4031 | 113558-89-7 | C21H27N3O3S | 401.52 | CC1=NC(CCN2CCC(C(C3=CC=C(NS(C)(=O)=O)C=C3)=O)CC2)=CC=C1 |
| EOS-AX7216 | VIP (human, rat, mouse, rabbit, canine, porcine) | 40077-57-4 | C147H238N44O42S | 3325.83 | |
| EOS-AX7217 | Methylthioadenosine | 2457-80-9 | C11H15N5O3S | 297.33 | CSC[C@](O1)([H])[C@](O)([H])[C@](O)([H])[C@]1([H])N2C=NC(C2=NC=N3)=C3N |
| EOS-AX7218 | BAY-598 | 186348-23-2 | C44H57NO17 | 871.92 | CC(C[C@@H]([C@H](C(O[C@H]1[C@]2([C@]3([C@H]([C@@]4([C@]5([C@@]([H])(C[C@@H]([C@]4(C([C@@H](C(C3(C)C)=C1C)OC(C)=O)=O)C)O)OC5)OC(C)=O)[H])OC(C6=CC=CC=C6)=O)OC(O2)=O)[H])=O)O)NC(OC(C)(C)C)=O)C |
| EOS-AX7219 | EPZ031686 | 1808011-22-4 | C26H34ClF3N4O4S | 591.09 | ClC1=CC(N2)=C(CC2=O)C=C1C(N[C@@]3([H])C[C@@](N4S(CC(CC5)CCN5CCCC(F)(F)F)(=O)=O)([H])CC[C@@]4([H])C3)=O |
| EOS-AX7220 | LiCl | 7447-41-8 | ClLi | 42.39 | [Cl-].[Li+] |
| EOS-AX7221 | AS8351 | 796-42-9 | C17H13N3O2 | 291.3 | OC(C=CC1=CC=CC=C12)=C2/C([H])=N/NC(C3=CC=NC=C3)=O |
| EOS-AX7222 | AMI5 | 17372-87-1 | C20H6Br4Na2O5 | 691.85 | BrC1=C([O-])C(Br)=C2C(C(C3=CC=CC=C3C([O-])=O)=C4C=C(Br)C(C(Br)=C4O2)=O)=C1.[Na+].[Na+] |
| EOS-AX7223 | BGP-15 | 66611-37-8 | C14H24Cl2N4O2 | 351.27 | N=C(NOCC(O)CN1CCCCC1)C2=CN=CC=C2.Cl.Cl |
| EOS-AX7224 | ZIP | 863987-12-6 | C12H25N3S4Zn | 404.99 | [S-]C(N(C)C)=S.[S-]C(N(C)C)=S.NC1CCCCC1.[Zn+2] |
| EOS-AX7225 | EPZ020411 | 1700663-41-7 | C25H38N4O3 | 442.59 | CN(CC1=CNN=C1C2=CC=C(O[C@@H]3C[C@@H](OCCC4CCOCC4)C3)C=C2)CCNC |
| EOS-AX7226 | PS-1145 | 431898-65-6 | C17H11ClN4O | 322.75 | ClC1=CC(C2=CC=NC=C2N3)=C3C(NC(C4=CN=CC=C4)=O)=C1 |
| EOS-AX7227 | Bioymifi | 1420071-30-2 | C22H12BrN3O4S | 494.32 | BrC1=CC=C(N(/C2=N\[H])C(/C(S2)=C([H])/C(O3)=CC=C3C4=CC5=C(C(O)=NC5=O)C=C4)=O)C=C1 |
| EOS-AX7228 | GSK-J1 sodium salt | C22H22N5NaO2 | 411.43 | [O-]C(CCNC1=CC(N2CCC3=C(CC2)C=CC=C3)=NC(C4=CC=CC=N4)=N1)=O.[Na+] | |
| EOS-AX7229 | Ro 31-8220 methanesulfonate | 138489-18-6 | C26H27N5O5S2 | 553.65 | CN1C=C(C(C(O)=NC2=O)=C2C(C3=CC=CC=C34)=CN4CCCSC(N)=N)C5=CC=CC=C51.CS(O)(=O)=O |
| EOS-AX7230 | ISRIB | 548470-11-7 | C22H24Cl2N2O4 | 451.34 | ClC1=CC=C(OC/C(O)=N/[C@@]2([H])CC[C@@](/N=C(O)/COC3=CC=C(Cl)C=C3)([H])CC2)C=C1 |
| EOS-AX7231 | BH3I-1 | 300817-68-9 | C15H14BrNO3S2 | 400.31 | CC(C(N(C1=S)C(/C(S1)=C([H])\C2=CC=C(Br)C=C2)=O)C(O)=O)C |
| EOS-AX7232 | RSL3 | 1219810-16-8 | C23H21ClN2O5 | 440.88 | COC(C1=CC=C([C@@]2([H])C3=C(C4=CC=CC=C4N3)C[C@](N2C(CCl)=O)([H])C(OC)=O)C=C1)=O |
| EOS-AX7233 | SIS3 | 521984-48-5 | C28H28ClN3O3 | 489.99 | CN1C(C2=CC=CC=C2)=C(C3=C1N=CC=C3)/C([H])=C([H])/C(N4CCC5=CC(OC)=C(OC)C=C5C4)=O.Cl |
| EOS-AX7234 | SU5614 | 1055412-47-9 | C15H13ClN2O | 272.73 | CC(C=C(N1)C)=C1/C([H])=C(C2=O)/C3=C(N2)C=CC(Cl)=C3 |
| EOS-AX7235 | Resazurin sodium salt | 62758-13-8 | C12H6NNaO4 | 251.17 | O=C1C=C2OC3=CC([O-])=CC=C3[N+]([O-])=C2C=C1.[Na+] |
| EOS-AX7236 | LY3023414 | 1386874-06-1 | C23H26N4O3 | 406.48 | O=C(N(C1=C2C3=CC(C4=CC(C(O)(C)C)=CN=C4)=CC=C3N=C1)C)N2C[C@H](C)OC |
| EOS-AX7237 | Valrocemide | 92262-58-3 | C10H20N2O2 | 200.28 | CCCC(CCC)C(NCC(N)=O)=O |
| EOS-AX7238 | Bohemine | 189232-42-6 | C18H24N6O | 340.42 | CC(N1C=NC(C1=NC(NCCCO)=N2)=C2NCC3=CC=CC=C3)C |
| EOS-AX7239 | NS 11394 | 951650-22-9 | C23H19N3O | 353.42 | CC(C1=CC(N=CN2C3=CC=CC(C4=CC=CC=C4C#N)=C3)=C2C=C1)(O)C |
| EOS-AX7240 | Casin | 425399-05-9 | C20H22N2O | 306.4 | OCCNC1CCCC2=C1NC3=C2C=C(C4=CC=CC=C4)C=C3 |
| EOS-AX7241 | BVT 2733 | 376640-41-4 | C17H21ClN4O3S2 | 428.96 | CC1=C(Cl)C=CC=C1S(NC2=NC(CC(N3CCN(CC3)C)=O)=CS2)(=O)=O |
| EOS-AX7242 | Tizoxanide | 173903-47-4 | C10H7N3O4S | 265.25 | OC1=C(C=CC=C1)C(NC2=NC=C(S2)[N+]([O-])=O)=O |
| EOS-AX7243 | Daprodustat(GSK1278863) | 960539-70-2 | C19H27N3O6 | 393.43 | O=C(O)CNC(C(C(N1C2CCCCC2)=O)C(N(C1=O)C3CCCCC3)=O)=O |
| EOS-AX7244 | ML241 | 1346528-06-0 | C23H24N4O | 372.46 | C1(CNC2=NC(N3CCOC4=CC=CC=C43)=NC5=C2CCCC5)=CC=CC=C1 |
| EOS-AX7245 | IC261 | 186611-52-9 | C18H17NO4 | 311.33 | COC(C=C1OC)=CC(OC)=C1/C([H])=C2C3=CC=CC=C3NC\2=O |
| EOS-AX7246 | CPI-1189 | 183619-38-7 | C13H18N2O2 | 234.29 | C/C(O)=N/C1=CC=C(C=C1)C(NC(C)(C)C)=O |
| EOS-AX7247 | IMR-1 | 310456-65-6 | C15H15NO5S2 | 353.41 | CCOC(COC1=C(OC)C=C(/C([H])=C(S2)\C(NC2=S)=O)C=C1)=O |
| EOS-AX7248 | Lu AF21934 | 1445605-23-1 | C14H16Cl2N2O2 | 315.2 | ClC1=C(C=C(C=C1)NC([C@]2(CCCC[C@]2(C(O)=N)[H])[H])=O)Cl |
| EOS-AX7249 | Opicapone | 923287-50-7 | C15H10Cl2N4O6 | 413.17 | CC1=C(C2=NOC(C3=CC(N(=O)=O)=C(O)C(O)=C3)=N2)C(Cl)=N(C(C)=C1Cl)=O |
| EOS-AX7250 | Beauvericin | 26048-05-5 | C45H57N3O9 | 783.95 | CC(C(OC([C@](N(C(C(O1)([H])C(C)C)=O)C)([H])CC2=CC=CC=C2)=O)([H])C(N([C@@](C(OC(C(N([C@@](C1=O)([H])CC3=CC=CC=C3)C)=O)([H])C(C)C)=O)([H])CC4=CC=CC=C4)C)=O)C |
| EOS-AX7251 | CC-115 | 1228013-15-7 | C16H16N8O | 336.35 | CCN1C(CN=C2C1=NC(C(C=CC(C3=NNC=N3)=N4)=C4C)=CN2)=O |
| EOS-AX7252 | RG 13022 | 136831-48-6 | C16H14N2O2 | 266.29 | N#C/C(C1=CC=CN=C1)=C/C2=CC=C(C(OC)=C2)OC |
| EOS-AX7253 | GLPG0634 analogue | 1206101-20-3 | C23H18N6O2 | 410.43 | N#CC1=NC=C(COC2=CC=C(C3=CC=CC4=N/C(NN34)=N\C(C5CC5)=O)C=C2)C=C1 |
| EOS-AX7254 | Fluensulfone | 318290-98-1 | C7H5ClF3NO2S2 | 291.7 | ClC1=CN=C(S(CC/C(F)=C(F)\F)(=O)=O)S1 |
| EOS-AX7255 | Microcystin-RR | 111755-37-4 | C49H75N13O12 | 1038.2 | CC(/C=C/[C@@H]([C@@H](C(N[C@H](CCC(N(C(C(N[C@@H]1C)=O)=C)C)=O)C(O)=O)=O)C)NC([C@@H](NC([C@H]([C@@H](NC([C@@H](NC1=O)CCCNC(N)=N)=O)C(O)=O)C)=O)CCCNC(N)=N)=O)=C\[C@H](C)[C@@H](OC)CC2=CC=CC=C2 |
| EOS-AX7256 | LLY507 | 1793053-37-8 | C36H42N6O | 574.76 | N#CC1=CC(C(NCCCN2CCCC2)=O)=CC(C3=CC=CC=C3N4CCN(CC4)CCN5C=C(C6=C5C=CC=C6)C)=C1 |
| EOS-AX7257 | Adox | 34240-05-6 | C10H11N5O4 | 265.23 | O=C(C(OC(CO)C([H])=O)N1C=NC2=C1N=CN=C2N)[H] |
| EOS-AX7258 | 3-Deazaadenosine | 6736-58-9 | C11H14N4O4 | 266.25 | NC1=C2C(N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)=CC=N1 |
| EOS-AX7259 | ML241 hydrochloride | C23H25ClN4O | 408.92 | C1(CNC2=NC(N3CCOC4=CC=CC=C43)=NC5=C2CCCC5)=CC=CC=C1.Cl | |
| EOS-AX7260 | S-Adenosylhomocysteine | 979-92-0 | C14H20N6O5S | 384.41 | O[C@@H]1[C@@H]([C@H](O[C@H]1N2C3=C(N=C2)C(N)=NC=N3)CSCC[C@@H](C(O)=O)N)O |
| EOS-AX7261 | Fomepizole | 7554-65-6 | C4H6N2 | 82.1 | CC1=CNN=C1 |
| EOS-AX7262 | Acetazolamide | 59-66-5 | C4H6N4O3S2 | 222.25 | C/C(O)=N/C1=NN=C(S(N)(=O)=O)S1 |
| EOS-AX7263 | 17-Hydroxyprogesterone | 68-96-2 | C21H30O3 | 330.46 | CC([C@@]1(O)CC[C@@]2([H])[C@]([C@]3([H])CC[C@@]21C)([H])CCC4=CC(CC[C@@]43C)=O)=O |
| EOS-AX7264 | Fenbufen | 36330-85-5 | C16H14O3 | 254.28 | O=C(C1=CC=C(C2=CC=CC=C2)C=C1)CCC(O)=O |
| EOS-AX7265 | Fenofibric acid | 42017-89-0 | C17H15ClO4 | 318.75 | CC(C(O)=O)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C |
| EOS-AX7266 | Oxolinic acid | 14698-29-4 | C13H11NO5 | 261.23 | CCN1C=C(C(O)=O)C(C2=CC(OCO3)=C3C=C21)=O |
| EOS-AX7267 | Trihexyphenidyl hydrochloride | 52-49-3 | C20H32ClNO | 337.93 | OC(C1=CC=CC=C1)(C2CCCCC2)CCN3CCCCC3.Cl |
| EOS-AX7268 | Bithionol | 97-18-7 | C12H6Cl4O2S | 356.05 | ClC1=CC(Cl)=C(O)C(SC2=CC(Cl)=CC(Cl)=C2O)=C1 |
| EOS-AX7269 | Fluphenazine dihydrochloride | 146-56-5 | C22H28Cl2F3N3OS | 510.44 | FC(F)(F)C1=CC(N(C2=CC=CC=C2S3)CCCN4CCN(CCO)CC4)=C3C=C1.Cl.Cl |
| EOS-AX7270 | Hexylresorcinol | 136-77-6 | C12H18O2 | 194.27 | CCCCCCC1=C(O)C=C(O)C=C1 |
| EOS-AX7271 | Amodiaquine dihydrochloride dihydrate | 6398-98-7 | C20H28Cl3N3O3 | 464.81 | CCN(CC1=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=CC=C1O)CC.Cl.Cl.O.O |
| EOS-AX7272 | Nitroxoline | 4008-48-4 | C9H6N2O3 | 190.16 | OC1=C2C(C=CC=N2)=C(N(=O)=O)C=C1 |
| EOS-AX7273 | Chlormadinone acetate | 302-22-7 | C23H29ClO4 | 404.93 | CC([C@@]1(OC(C)=O)CC[C@@]2([H])[C@]([C@]3([H])CC[C@@]21C)([H])C=C(Cl)C4=CC(CC[C@]34C)=O)=O |
| EOS-AX7274 | Diflunisal | 22494-42-4 | C13H8F2O3 | 250.2 | FC1=CC(F)=C(C2=CC(C(O)=O)=C(O)C=C2)C=C1 |
| EOS-AX7275 | Itopride hydrochloride | 122892-31-3 | C20H27ClN2O4 | 394.89 | CN(CCOC1=CC=C(CNC(C2=CC(OC)=C(OC)C=C2)=O)C=C1)C.Cl |
| EOS-AX7276 | (+/-)-Sulfinpyrazone | 57-96-5 | C23H20N2O3S | 404.48 | O=C(N1C2=CC=CC=C2)C(C(N1C3=CC=CC=C3)=O)CCS(C4=CC=CC=C4)=O |
| EOS-AX7277 | Hexachlorophene | 70-30-4 | C13H6Cl6O2 | 406.9 | ClC1=CC(Cl)=C(Cl)C(CC2=C(Cl)C(Cl)=CC(Cl)=C2O)=C1O |
| EOS-AX7278 | Zolpidem | 82626-48-0 | C19H21N3O | 307.39 | CC1=CC=C(C(N=C2C=CC(C)=CN32)=C3CC(N(C)C)=O)C=C1 |
| EOS-AX7279 | Netupitant | 290297-26-6 | C30H32F6N4O | 578.59 | CC1=CC=CC=C1C2=CC(N3CCN(CC3)C)=NC=C2N(C(C(C)(C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4)C)=O)C |
| EOS-AX7280 | Hydroxyprogesterone caproate | 630-56-8 | C27H40O4 | 428.6 | CCCCCC(O[C@]1(C(C)=O)CC[C@@]2([H])[C@]([C@]3([H])CC[C@@]21C)([H])CCC4=CC(CC[C@@]43C)=O)=O |
| EOS-AX7281 | Fluoxymesterone | 76-43-7 | C20H29FO3 | 336.44 | C[C@]12CCC(C=C1CC[C@@]3([H])[C@]4([H])CC[C@@](C)(O)[C@@](C[C@H](O)[C@@]32F)4C)=O |
| EOS-AX7282 | Vitamin E | 59-02-9 | C29H50O2 | 430.71 | CC(CCC[C@H](C)CCC[C@H](C)CCC[C@@]1(CCC2=C(C(O)=C(C(C)=C2O1)C)C)C)C |
| EOS-AX7283 | Escin | 6805-41-0 | C55H86O24 | 1131.26 | CC1(CC2C3=CCC4[C@@](C5CC[C@@]4(C)[C@](C[C@@H](O)[C@@]2(CO)[C@@H](OC(C)=O)[C@@H]1OC(/C(C)=C\C)=O)3C)(C)CC[C@H](O[C@@H]6[C@@H](O[C@@H]7[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O7)[C@H](O)[C@@H](O[C@@H]8[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O8)[C@H](C(O)=O)O6)[C@@]5( |
| EOS-AX7284 | CarbinoxaMine Maleate | 3505-38-2 | C16H19ClN2O.C4H4O4 | 406.86 | CN(CCOC(C1=NC=CC=C1)C2=CC=C(Cl)C=C2)C.OC(/C=C\C(O)=O)=O |
| EOS-AX7285 | Etretinate | 54350-48-0 | C23H30O3 | 354.48 | CCOC(/C=C(/C=C/C=C(/C=C/C1=C(C=C(OC)C(C)=C1C)C)C)C)=O |
| EOS-AX7286 | Eugenol | 97-53-0 | C10H12O2 | 164.2 | C=CCC1=CC(OC)=C(O)C=C1 |
| EOS-AX7287 | Picolinamide | 1452-77-3 | C6H6N2O | 122.12 | NC(C1=CC=CC=N1)=O |
| EOS-AX7288 | Diethylmaleate | 141-05-9 | C8H12O4 | 172.18 | CCOC(/C=C\C(OCC)=O)=O |
| EOS-AX7289 | Benzamide | 55-21-0 | C7H7NO | 121.14 | NC(C1=CC=CC=C1)=O |
| EOS-AX7290 | Isatin | 91-56-5 | C8H5NO2 | 147.13 | O=C(C1=O)C2=C(N1)C=CC=C2 |
| EOS-AX7291 | Benzenesulfonamide | 98-10-2 | C6H7NO2S | 157.19 | NS(C1=CC=CC=C1)(=O)=O |
| EOS-AX7292 | Lauric Acid | 143-07-7 | C12H24O2 | 200.32 | CCCCCCCCCCCC(O)=O |
| EOS-AX7293 | Cinnarizine | 298-57-7 | C26H28N2 | 368.51 | C1(/C=C/CN2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)=CC=CC=C1 |
| EOS-AX7294 | Perphenazine | 58-39-9 | C21H26ClN3OS | 403.97 | ClC1=CC(N(C2=CC=CC=C2S3)CCCN4CCN(CCO)CC4)=C3C=C1 |
| EOS-AX7295 | RO9021 | 1446790-62-0 | C18H25N7O | 355.44 | O=C(C1=NN=C(N[C@H]2[C@@H](N)CCCC2)C=C1NC3=NC(C)=C(C)C=C3)N |
| EOS-AX7296 | Vacquinol-1 | 5428-80-8 | C21H23Cl3N2O | 425.78 | OC(C1=CC(C2=CC=C(Cl)C=C2)=NC3=CC=CC=C13)C4NCCCC4 |
| EOS-AX7297 | PIK-III | 1383716-40-2 | C17H17N7 | 319.36 | NC1=NC=C(C2=NC(NC3=CC=NC=C3)=NC=C2)C(CC4CC4)=N1 |
| EOS-AX7298 | PRT-060318 | 1194961-19-7 | C18H27Cl3N6O | 449.81 | O=C(C1=CN=C(N[C@H]2[C@@H](N)CCCC2)N=C1NC3=CC=CC(C)=C3)N |
| EOS-AX7299 | AZ6102 | 1645286-75-4 | C25H28N6O | 428.53 | O=C1NC(C2=CC=C(C3=CN=C(N4C[C@H](C)N[C@H](C)C4)C=C3C)C=C2)=NC5=C1C=CN5C |
| EOS-AX7300 | A-1155463 | 1235034-55-5 | C35H32FN5O4S2 | 669.79 | O=C(C1=C(CCCOC2=CC=C(C#CCN(C)C)C=C2F)SC(N3CC4=C(C=CC=C4C(NC5=NC6=CC=CC=C6S5)=O)CC3)=N1)O |
| EOS-AX7301 | A-1331852 | 1430844-80-6 | C38H38N6O3S | 658.81 | O=C(C1=NC(N2CC3=C(C=CC=C3C(NC4=NC5=CC=CC=C5S4)=O)CC2)=CC=C1C6=C(C)N(CC78CC9CC(C8)CC(C9)C7)N=C6)O |
| EOS-AX7302 | FRAX486 | 1232030-35-1 | C25H23Cl2FN6O | 513.39 | O=C1C(C2=CC=C(Cl)C=C2Cl)=CC3=CN=C(NC4=CC=C(N5CCNCC5)C(F)=C4)N=C3N1CC |
| EOS-AX7303 | MI-136 | 1628316-74-4 | C23H21F3N6S | 470.51 | N#CC(N1)=CC2=C1C=CC(CN3CCC(NC4=C(C=C(CC(F)(F)F)S5)C5=NC=N4)CC3)=C2 |
| EOS-AX7304 | 4-Hydroxytamoxifen | 68392-35-8 | C26H29NO2 | 387.51 | OC1=CC=C(/C(C2=CC=C(OCCN(C)C)C=C2)=C(C3=CC=CC=C3)\CC)C=C1 |
| EOS-AX7305 | OICR-9429 | 1801787-56-3 | C29H32F3N5O3 | 555.59 | O=C(C(C(C(F)(F)F)=C1)=CNC1=O)NC2=CC(C3=CC=CC(CN4CCOCC4)=C3)=CC=C2N5CCN(C)CC5 |
| EOS-AX7306 | I-BRD9 | 1714146-59-4 | C22H22F3N3O3S2 | 497.55 | N=C(C(S1)=CC2=C1C(C3=CC=CC(C(F)(F)F)=C3)=CN(CC)C2=O)NC(CC4)CCS4(=O)=O |
| EOS-AX7307 | LJH685 | 1627710-50-2 | C22H21F2N3O | 381.42 | OC1=C(F)C=C(C2=C(C3=CC=C(N4CCN(C)CC4)C=C3)C=CN=C2)C=C1F |
| EOS-AX7308 | CC-223 | 1228013-30-6 | C21H27N5O3 | 397.47 | O=C1N([C@H]2CC[C@H](OC)CC2)C3=NC(C4=CN=C(C(O)(C)C)C=C4)=CN=C3NC1 |
| EOS-AX7309 | PD-1/PD-L1 inhibitor 1 | 1675201-83-8 | C29H33NO5 | 475.58 | O=C([C@H]1N(CC2=C(OC)C=C(OCC3=CC=CC(C4=CC=CC=C4)=C3C)C=C2OC)CCCC1)O |
| EOS-AX7310 | GSK2292767 | 1254036-66-2 | C24H28N6O5S | 512.58 | CS(=O)(NC1=CC(C2=CC3=C(C(C4=NC=C(CN5C[C@@H](C)O[C@@H](C)C5)O4)=C2)C=NN3)=CN=C1OC)=O |
| EOS-AX7311 | MRT68921 | 1190379-70-4 | C25H34N6O·xHCl | 434.58 | O=C(C1CCC1)NCCCNC2=NC(NC3=CC4=C(CN(C)CC4)C=C3)=NC=C2C5CC5.[xHCl] |
| EOS-AX7312 | STA-21 | 111540-00-2 | C19H14O4 | 306.31 | O=C1CC(C)CC(C1=C2C3=O)=CC=C2C(C4=C3C=CC=C4O)=O |
| EOS-AX7313 | LOXO-101 | 1223405-08-0 | C21H24F2N6O6S | 526.51 | O=S(O)(O)=O.O=C(N1C[C@@H](O)CC1)NC2=C3N=C(N4[C@@H](C5=CC(F)=CC=C5F)CCC4)C=CN3N=C2 |
| EOS-AX7314 | PLX7904 | 1393465-84-3 | C24H22F2N6O3S | 512.53 | O=C(C1=CNC2=NC=C(C3=CN=C(C4CC4)N=C3)C=C21)C5=C(F)C=CC(NS(=O)(N(CC)C)=O)=C5F |
| EOS-AX7315 | AZD8835 | 1620576-64-8 | C22H31N9O3 | 469.54 | O=C(N1CCC(C2=NN(CC)C(C3=NC(C4=NN=C(C(C)(C)C)O4)=C(N)N=C3)=N2)CC1)CCO |
| EOS-AX7316 | VPS34-IN1 | 1383716-33-3 | C21H24ClN7O | 425.91 | CC(CNC1=NC=C(C(CC2CC2)=N1)C3=NC(NC4=CC(Cl)=NC=C4)=NC=C3)(O)C |
| EOS-AX7317 | FRAX1036 | 1432908-05-8 | C28H32ClN7O | 518.05 | O=C1C(C2=CC=C(C3=NC(C)=CN=C3)C=C2Cl)=CC4=CN=C(NCCC5CCN(C)CC5)N=C4N1CC |
| EOS-AX7318 | Tubercidin | 69-33-0 | C11H14N4O4 | 266.25 | NC1=NC=NC2=C1C=CN2[C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3 |
| EOS-AX7319 | GSK591 | 1616391-87-7 | C22H28N4O2 | 380.48 | O=C(C1=CC(NC2CCC2)=NC=C1)NC[C@H](O)CN3CC4=C(C=CC=C4)CC3 |
| EOS-AX7320 | MS023 | 1831110-54-3 | C17H25N3O | 287.4 | NCCN(C)CC1=CNC=C1C2=CC=C(OC(C)C)C=C2 |
| EOS-AX7321 | BI-9564 | 1883429-22-8 | C20H23N3O3 | 353.41 | O=C1N(C)C=C(C2=CC(OC)=C(CN(C)C)C=C2OC)C3=CC=NC=C13 |
| EOS-AX7322 | ACP-196 | 1420477-60-6 | C26H23N7O2 | 465.51 | O=C(NC1=NC=CC=C1)C2=CC=C(C3=C4C(N)=NC=CN4C([C@H]5N(C(C#CC)=O)CCC5)=N3)C=C2 |
| EOS-AX7323 | RHPS4 | 390362-78-4 | C23H20F2N2O4S | 458.48 | FC1=CC=C(N(C)C2=C3C4=[N+](C)C5=C(C=C(F)C=C5)C3=CC(C)=C2)C4=C1.COS(=O)([O-])=O |
| EOS-AX7324 | BMS-582949 | 623152-17-0 | C22H26N6O2 | 406.48 | O=C(C1=CN2N=CN=C(NC3=CC(C(NC4CC4)=O)=CC=C3C)C2=C1C)NCCC |
| EOS-AX7325 | Pamapimod (R-1503, Ro4402257) | 449811-01-2 | C19H20F2N4O4 | 406.38 | O=C1C(OC2=CC=C(F)C=C2F)=CC3=CN=C(NC(CCO)CCO)N=C3N1C |
| EOS-AX7326 | Sivelestat (ONO-5046) | 127373-66-4 | C20H22N2O7S | 434.46 | O=C(O)CNC(C1=CC=CC=C1NS(=O)(C2=CC=C(OC(C(C)(C)C)=O)C=C2)=O)=O |
| EOS-AX7327 | NSC348884 | 81624-55-7 | C38H40N10 | 636.79 | CC1=CC=C2N=C(CN(CC3=NC4=CC=C(C)C=C4N3)CCN(CC5=NC6=CC=C(C)C=C6N5)CC7=NC8=CC=C(C)C=C8N7)NC2=C1 |
| EOS-AX7328 | PD-1/PD-L1 Inhibitor 3 | 1629654-95-0 | C89H126N24O18S | 1852.17 | O=C(NCC(N)=O)[C@H]1NC([C@@H](NC([C@@H](N(C)C([C@H](CCCC)N(C)C([C@H](CC2=CNC3=C2C=CC=C3)NC([C@H](CO)NC([C@H](CC4=CNC5=C4C=CC=C5)NC(CN(C)C([C@H](CC(C)C)NC([C@@H](NC([C@H]6N(C([C@H](CC(N)=O)NC([C@@H](N(C(C(NC(CSC1)=O)CC7=CC=CC=C7)=O)C)C)=O)=O)CCC6)=O)CC8=CN= |
| EOS-AX7329 | ON123300 | 1357470-29-1 | C24H27N7O | 429.52 | N#CC1=CC2=CN=C(NC3=CC=C(N4CCN(C)CC4)C=C3)N=C2N(C5CCCC5)C1=O |
| EOS-AX7330 | AMG 337 | 1173699-31-4 | C23H22FN7O3 | 463.46 | CN1N=CC(C2=CN3C([C@@H](C)N4C=CC(N=CC(OCCOC)=C5)=C5C4=O)=NN=C3C(F)=C2)=C1 |
| EOS-AX7331 | GSK481 | 1622849-58-4 | C21H19N3O4 | 377.39 | O=C(C1=NOC(CC2=CC=CC=C2)=C1)N[C@H]3COC4=CC=CC=C4N(C)C3=O |
| EOS-AX7332 | Verubecestat (MK-8931) | 1286770-55-5 | C19H18F5N5O5S | 523.43 | O=C(C1=NC=C(F)C=C1)NC2=CC=C(F)C([C@@](C3)(C)NC(N(C)S3(=O)=O)=N)=C2.FC(F)(F)C(O)=O |
| EOS-AX7333 | BI-7273 | 1883429-21-7 | C20H23N3O3 | 353.41 | O=C1N(C)C=C(C2=CC(OC)=C(CN(C)C)C(OC)=C2)C3=CC=NC=C13 |
| EOS-AX7334 | PF-CBP1 | C29H37ClN4O3 | 525.08 | CCCOC1=CC=C(CCC2=NC3=CC(C4=C(C)ON=C4C)=CC=C3N2CCN5CCOCC5)C=C1.Cl | |
| EOS-AX7335 | ReACp53 | C108H206N52O24 | 2617.13 | CC[C@]([C@@](/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])CCCNC(N) | |
| EOS-AX7336 | BFH772 | 890128-81-1 | C23H16F3N3O3 | 439.39 | O=C(C1=C2C=CC(OC3=NC=NC(CO)=C3)=CC2=CC=C1)NC4=CC=CC(C(F)(F)F)=C4 |
| EOS-AX7337 | DL-AP4 | 20263-07-4 | C4H10NO5P | 183.1 | OP(O)(CC[C@@H](C(O)=O)N)=O |
| EOS-AX7338 | D-AP4 | 78739-01-2 | C4H10NO5P | 183.1 | OP(O)(CC[C@H](C(O)=O)N)=O |
| EOS-AX7339 | L-AP4 | 23052-81-5 | C4H10NO5P | 183.1 | OP(O)(CC[C@@H](C(O)=O)N)=O |
| EOS-AX7340 | DL-AP7 | 78966-69-5 | C7H16NO5P | 225.18 | OP(O)(CCCCC[C@@H](C(O)=O)N)=O |
| EOS-AX7341 | DL-AP5 | 76326-31-3 | C5H12NO5P | 197.13 | OP(O)(CCC[C@H](C(O)=O)N)=O |
| EOS-AX7342 | D-AP5 | 79055-68-8 | C5H12NO5P | 197.13 | OP(O)(CCC[C@H](C(O)=O)N)=O |
| EOS-AX7343 | L-AP5 | 79055-67-7 | C5H12NO5P | 197.13 | OP(O)(CCC[C@H](C(O)=O)N)=O |
| EOS-AX7344 | (-)-Bicuculline methobromide | 73604-30-5 | C21H20BrNO6 | 462.3 | O=C1O[C@@H](C2=CC=C3OCOC3=C21)[C@@H](C4=C5)[N+](C)(C)CCC4=CC6=C5OCO6.[Br-] |
| EOS-AX7345 | Dihydrokainic acid | 52497-36-6 | C10H17NO4 | 215.25 | OC([C@H]1NC[C@H](C(C)C)[C@@H]1CC(O)=O)=O |
| EOS-AX7346 | γDGG | 6729-55-1 | C7H12N2O5 | 204.18 | O=C(CC[C@@H](C(O)=O)N)NCC(O)=O |
| EOS-AX7347 | (-)-Bicuculline methochloride | 53552-05-9 | C21H20ClNO6 | 417.85 | O=C1O[C@H](C2=CC=C3OCOC3=C21)[C@@H](C4=C5)[N+](C)(C)CCC4=CC6=C5OCO6.[Cl-] |
| EOS-AX7348 | S-Sulfo-L-cysteine sodium salt | 7381-67-1 | C3H6NO5S2Na | 223.19 | N[C@@](C([O-])=O)([H])CSS(O)(=O)=O.[Na+] |
| EOS-AX7349 | D-AP7 | 81338-23-0 | C7H16NO5P | 225.18 | OP(O)(CCCCC[C@@H](C(O)=O)N)=O |
| EOS-AX7350 | (RS)-AMPA | 74341-63-2 | C7H10N2O4 | 186.17 | O=C1NOC(C)=C1C[C@@H](C(O)=O)N |
| EOS-AX7351 | (RS)-CPP | 100828-16-8 | C8H17N2O5P | 252.21 | OC([C@@H]1NCCN(CCCP(O)(O)=O)C1)=O |
| EOS-AX7352 | Phaclofen | 114012-12-3 | C9H13ClNO3P | 249.63 | ClC1=CC=C(C=C1)[C@@H](CN)CP(O)(O)=O |
| EOS-AX7353 | ZAPA sulfate | 371962-01-5 | C4H6N2O2S.H2SO4 | 244.24 | N=C(S/C([H])=C([H])\C(O)=O)N.OS(O)(=O)=O |
| EOS-AX7354 | TACA | 38090-53-8 | C4H7NO2 | 101.1 | OC(/C=C/CN)=O |
| EOS-AX7355 | L-(-)-threo-3-Hydroxyaspartic acid | 7298-99-9 | C4H7NO5 | 149.1 | O[C@H](C(O)=O)[C@@H](C(O)=O)N |
| EOS-AX7356 | cis-ACPD | 477331-06-9 | C7H11NO4 | 173.17 | OC([C@]1(C[C@@H](C(O)=O)CC1)N)=O |
| EOS-AX7357 | (±)-trans-ACPD | 67684-64-4 | C7H11NO4 | 173.17 | OC([C@]1(C[C@H](C(O)=O)CC1)N)=O |
| EOS-AX7358 | L-Quisqualic acid | 52809-07-1 | C5H7N3O5 | 189.13 | OC([C@@H](CN1OC(NC1=O)=O)N)=O |
| EOS-AX7359 | CNQX | 115066-14-3 | C9H4N4O4 | 232.16 | O=C1NC2=CC([N+]([O-])=O)=C(C#N)C=C2NC1=O |
| EOS-AX7360 | Homoquinolinic acid | 490-75-5 | C8H7NO4 | 181.15 | OC(CC1=CC=CN=C1C(O)=O)=O |
| EOS-AX7361 | Hypotaurine | 300-84-5 | C2H7NO2S | 109.14 | OS(CCN)=O |
| EOS-AX7362 | L-Cysteinesulfinic acid | 1115-65-7 | C3H7NO4S | 153.15 | OC([C@H](CS(O)=O)N)=O |
| EOS-AX7363 | Kainic acid | 487-79-6 | C10H15NO4 | 213.23 | OC([C@H]1NC[C@H](C(C)=C)[C@@H]1CC(O)=O)=O |
| EOS-AX7364 | Kynurenic acid | 492-27-3 | C10H7NO3 | 189.17 | O=C1C2=CC=CC=C2NC(C(O)=O)=C1 |
| EOS-AX7365 | Quinolinic acid | 89-00-9 | C7H5NO4 | 167.12 | OC(C1=CC=CN=C1C(O)=O)=O |
| EOS-AX7366 | Guvacine hydrochloride | 6027-91-4 | C6H9NO2.HCl | 163.6 | OC(C1=CCCNC1)=O.Cl |
| EOS-AX7367 | Isoguvacine hydrochloride | 68547-97-7 | C6H9NO2.HCl | 163.6 | OC(C1=CCNCC1)=O.Cl |
| EOS-AX7368 | (±)-Nipecotic acid | 60252-41-7 | C6H11NO2 | 129.16 | OC([C@@H]1CCCNC1)=O |
| EOS-AX7369 | 7-Chlorokynurenic acid | 18000-24-3 | C10H6ClNO3 | 223.62 | ClC1=CC=C2C(NC(C(O)=O)=CC2=O)=C1 |
| EOS-AX7370 | O-Phospho-L-serine | 407-41-0 | C3H8NO6P | 185.07 | [O-]C([C@H](COP([O-])([O-])=O)[NH3+])=O |
| EOS-AX7371 | 2-Hydroxysaclofen | 117354-64-0 | C9H12ClNO4S | 265.71 | ClC1=CC=C(C=C1)[C@](CS(O)(=O)=O)(CN)O |
| EOS-AX7372 | Saclofen | 125464-42-8 | C9H12ClNO3S | 249.72 | ClC1=CC=C(C=C1)[C@H](CN)CS(O)(=O)=O |
| EOS-AX7373 | (R)-CPP | 126453-07-4 | C8H17N2O5P | 252.21 | OC([C@@H]1NCCN(CCCP(O)(O)=O)C1)=O |
| EOS-AX7374 | (R)-AMPA | 83654-13-1 | C7H10N2O4 | 186.17 | O=C1NOC(C)=C1C[C@H](C(O)=O)N |
| EOS-AX7375 | (S)-AMPA | 83643-88-3 | C7H10N2O4 | 186.17 | O=C1NOC(C)=C1C[C@@H](C(O)=O)N |
| EOS-AX7376 | ACBC | 22264-50-2 | C5H9NO2 | 115.13 | OC(C1(CCC1)N)=O |
| EOS-AX7377 | 2,4-Dihydroxyphenylacetyl-L-asparagine | 111872-98-1 | C12H14N2O6 | 282.25 | O=C(CC(C(O)=C1)=CC=C1O)N[C@@H](C(O)=O)CC(N)=O |
| EOS-AX7378 | Domoic acid | 14277-97-5 | C15H21NO6 | 311.33 | OC([C@H]1NC[C@H](/C(C)=C\C=C\[C@H](C(O)=O)C)[C@@H]1CC(O)=O)=O |
| EOS-AX7379 | cis-ACBD | 73550-55-7 | C6H9NO4 | 159.14 | OC([C@]1(C[C@H](C(O)=O)C1)N)=O |
| EOS-AX7380 | (R)-(+)-HA-966 | 123931-04-4 | C4H8N2O2 | 116.12 | ON(C1=O)CC[C@H]1N |
| EOS-AX7381 | (S)-(-)-HA-966 | 111821-58-0 | C4H8N2O2 | 116.12 | ON(C1=O)CC[C@@H]1N |
| EOS-AX7382 | (1S,3R)-ACPD | 111900-32-4 | C7H11NO4 | 173.17 | OC([C@]1(C[C@H](C(O)=O)CC1)N)=O |
| EOS-AX7383 | Ibotenic acid | 2552-55-8 | C5H6N2O4 | 158.11 | OC([C@H](C(ON1)=CC1=O)N)=O |
| EOS-AX7384 | 5,7-Dichlorokynurenic acid | 131123-76-7 | C10H5Cl2NO3 | 258.06 | ClC1=C2C(NC(C(O)=O)=CC2=O)=CC(Cl)=C1 |
| EOS-AX7385 | Muscimol | 2763-96-4 | C4H6N2O2 | 114.1 | O=C1NOC(CN)=C1 |
| EOS-AX7386 | N-(4-Hydroxyphenylacetyl)spermine | 130210-32-1 | C18H32N4O2 | 336.48 | O=C(CC(C=C1)=CC=C1O)NCCCNCCCCNCCCN |
| EOS-AX7387 | L-trans-2,4-PDC | 64769-66-0 | C6H9NO4 | 159.14 | OC([C@@H]1C[C@@H](C(O)=O)NC1)=O |
| EOS-AX7388 | (S)-(-)-5-Fluorowillardiine | 140187-23-1 | C7H8FN3O4 | 217.16 | FC1=CN(C(NC1=O)=O)C[C@@H](C(O)=O)N |
| EOS-AX7389 | (S)-(-)-5-Iodowillardiine | 140187-25-3 | C7H8IN3O4 | 325.06 | IC1=CN(C(NC1=O)=O)C[C@@H](C(O)=O)N |
| EOS-AX7390 | (RS)-4-Carboxy-3-hydroxyphenylglycine | 134052-66-7 | C9H9NO5 | 211.17 | OC1=CC([C@@H](C(O)=O)N)=CC=C1C(O)=O |
| EOS-AX7391 | (RS)-(Tetrazol-5-yl)glycine | 138199-51-6 | C3H5N5O2 | 143.1 | OC([C@H](C1=NNN=N1)N)=O |
| EOS-AX7392 | (S)-4-Carboxy-3-hydroxyphenylglycine | 85148-82-9 | C9H9NO5 | 211.17 | OC1=CC([C@@H](C(O)=O)N)=CC=C1C(O)=O |
| EOS-AX7393 | (RS)-4-Carboxyphenylglycine | 7292-81-1 | C9H9NO4 | 195.17 | OC([C@H](C1=CC=C(C(O)=O)C=C1)N)=O |
| EOS-AX7394 | (R)-4-Carboxyphenylglycine | 134052-68-9 | C9H9NO4 | 195.17 | OC(CNC1=CC=C(C(O)=O)C=C1)=O |
| EOS-AX7395 | (S)-4-Carboxyphenylglycine | 134052-73-6 | C9H9NO4 | 195.17 | OC(CNC1=CC=C(C(O)=O)C=C1)=O |
| EOS-AX7396 | (RS)-3-Hydroxyphenylglycine | 31932-87-3 | C8H9NO3 | 167.16 | OC1=CC([C@@H](C(O)=O)N)=CC=C1 |
| EOS-AX7397 | (S)-3-Hydroxyphenylglycine | 71301-82-1 | C8H9NO3 | 167.16 | N[C@@](C(O)=O)([H])C1=CC(O)=CC=C1 |
| EOS-AX7398 | (R)-3-Carboxy-4-hydroxyphenylglycine | 13861-03-5 | C9H9NO5 | 211.17 | N[C@](C(O)=O)([H])C1=CC(C(O)=O)=C(O)C=C1 |
| EOS-AX7399 | (S)-3-Carboxy-4-hydroxyphenylglycine | 55136-48-6 | C9H9NO5 | 211.17 | OC1=CC=C(C=C1C(O)=O)[C@H](C(O)=O)N |
| EOS-AX7400 | L-CCG-lll | 117857-95-1 | C6H9NO4 | 159.14 | N[C@@](C(O)=O)([H])[C@@]1([H])C[C@@]1([H])C(O)=O |
| EOS-AX7401 | L-CCG-l | 117857-93-9 | C6H9NO4 | 159.14 | OC([C@@H]1[C@@H]([C@@H](C(O)=O)N)C1)=O |
| EOS-AX7402 | (RS)-MCPG | 146669-29-6 | C10H11NO4 | 209.2 | OC([C@](C1=CC=C(C(O)=O)C=C1)(C)N)=O |
| EOS-AX7403 | (S)-MCPG | 150145-89-4 | C10H11NO4 | 209.2 | OC([C@](C1=CC=C(C(O)=O)C=C1)(C)N)=O |
| EOS-AX7404 | L-AP6 | 78944-89-5 | C6H14NO5P | 211.15 | OP(O)(CCCC[C@@H](C(O)=O)N)=O |
| EOS-AX7405 | (RS)-3,5-DHPG | 19641-83-9 | C8H9NO4 | 183.16 | NC(C(O)=O)C1=CC(O)=CC(O)=C1 |
| EOS-AX7406 | nor-Binaltorphimine dihydrochloride | 113158-34-2 | C40H43N3O6.2HCl | 734.72 | OC1=C(O2)C3=C(C[C@]4([H])[C@]5(O)CC(C(C[C@@]6(O)[C@@]7([H])CC8=C9C(O%10)=C(O)C=C8)=C%11[C@@]%10([H])[C@@]69CCN7CC%12CC%12)=C(N%11)[C@@]2([H])[C@]35CCN4CC%13CC%13)C=C1.Cl.Cl |
| EOS-AX7407 | 2-BFI hydrochloride | 89196-95-2 | C11H11ClN2O | 222.67 | C12=CC=CC=C1OC(C3=NCCN3)=C2.Cl |
| EOS-AX7408 | 1-Acetyl-4-methylpiperazine hydrochloride | 144205-68-5 | C7H14N2O.HCl | 178.66 | CC(N1CCN(CC1)C)=O.Cl |
| EOS-AX7409 | 4-Acetyl-1,1-dimethylpiperazinium iodide | 75667-84-4 | C8H17IN2O | 284.14 | O=C(C)N1CC[N+](C)(C)CC1.[I-] |
| EOS-AX7410 | (±)-Acetylcarnitine chloride | 2504-11-2 | C9H18ClNO4 | 239.7 | OC(C[C@H](C[N+](C)(C)C)OC(C)=O)=O.[Cl-] |
| EOS-AX7411 | N-Acetyltryptamine | 1016-47-3 | C12H14N2O | 202.26 | O=C(C)NCCC1=CNC2=CC=CC=C12 |
| EOS-AX7412 | (±)-1-(1,2-Diphenylethyl)piperidine maleate | 207461-99-2 | C19H23N.C4H4O4 | 381.47 | O=C(O)/C([H])=C([H])\C(O)=O.C1(CC(N2CCCCC2)C3=CC=CC=C3)=CC=CC=C1 |
| EOS-AX7413 | W-13 hydrochloride | 88519-57-7 | C14H17ClN2O2S.HCl | 349.27 | ClC1=CC=CC2=CC(S(=O)(NCCCCN)=O)=CC=C21.Cl |
| EOS-AX7414 | W-5 hydrochloride | 61714-25-8 | C16H22N2O2S.HCl | 342.88 | O=S(NCCCCCCN)(C1=CC=CC2=CC=CC=C12)=O.Cl |
| EOS-AX7415 | W-7 hydrochloride | 61714-27-0 | C16H21ClN2O2S.HCl | 377.33 | ClC1=C2C(C(S(=O)(NCCCCCCN)=O)=CC=C2)=CC=C1.Cl |
| EOS-AX7416 | W-9 hydrochloride | 69762-85-2 | C16H21ClN2O2S.HCl | 377.33 | ClC1=CC=CC2=CC(S(=O)(NCCCCCCN)=O)=CC=C21.Cl |
| EOS-AX7417 | NBQX | 118876-58-7 | C12H8N4O6S | 336.28 | O=S(N)(C1=CC=CC(C1=C2[N+]([O-])=O)=C(C(NC3=O)=C2)NC3=O)=O |
| EOS-AX7418 | A-7 hydrochloride | 79127-24-5 | C20H29ClN2O2S.HCl | 433.44 | ClC1=C2C(C(S(=O)(NCCCCCCCCCCN)=O)=CC=C2)=CC=C1.Cl |
| EOS-AX7419 | SKF 97541 | 127729-35-5 | C4H12NO2P | 137.12 | O[P@@](CCCN)(C)=O |
| EOS-AX7420 | Arecaidine but-2-ynyl ester tosylate | 119630-77-2 | C11H15NO2.C7H8SO3 | 365.44 | CC#CCOC(C(C1)=CCCN1C)=O.CC2=CC=C(S(O)(=O)=O)C=C2 |
| EOS-AX7421 | Arecaidine propargyl ester tosylate | 147202-94-6 | C10H13NO2.C7H8SO3 | 351.42 | OS(=O)(C1=CC=C(C)C=C1)=O.O=C(C2=CCCN(C)C2)OCC#C |
| EOS-AX7422 | 3-Methyl-GABA | 71424-95-8 | C10 H8 O6 S2 . 2 C5 H11 N O2 | 522.58 | OS(C1=CC=CC2=C1C=CC=C2S(O)(=O)=O)(=O)=O.CC(CN)CC(O)=O.CC(CN)CC(O)=O |
| EOS-AX7423 | Ambenonium dichloride | 115-79-7 | C28H42Cl4N4O2 | 608.48 | ClC1=CC=CC=C1C[N+](CC)(CC)CCNC(C(NCC[N+](CC)(CC)CC2=CC=CC=C2Cl)=O)=O.[Cl-].[Cl-] |
| EOS-AX7424 | Arcaine sulfate | 14923-17-2 | C6H16N6.H2SO4 | 270.31 | OS(O)(=O)=O.N/C(N)=N\CCCC/N=C(N)\N |
| EOS-AX7425 | Spaglumic acid | 3106-85-2 | C11H16N2O8 | 304.26 | O=C([C@@H](CC(O)=O)NC(C)=O)N[C@H](C(O)=O)CCC(O)=O |
| EOS-AX7426 | (S)-(-)-Atenolol | 93379-54-5 | C14H22N2O3 | 266.34 | O[C@H](COC1=CC=C(CC(N)=O)C=C1)CNC(C)C |
| EOS-AX7427 | N-Acetylglycyl-D-glutamic acid | 135701-69-8 | C9H14N2O6 | 246.22 | OC([C@@H](CCC(O)=O)NC(CNC(C)=O)=O)=O |
| EOS-AX7428 | β-CCB | 84454-35-3 | C16H16N2O2 | 268.31 | O=C(C1=NC=C2NC3=CC=CC=C3C2=C1)OCCCC |
| EOS-AX7429 | MDL 73005EF hydrochloride | 102908-60-1 | C20H26N2O4.HCl | 394.9 | O=C(N1CCNCC2COC3=CC=CC=C3O2)CC4(CC1=O)CCCC4.Cl |
| EOS-AX7430 | MDL 72832 hydrochloride | 113777-40-5 | C22H30N2O4.HCl | 422.95 | O=C(N1CCCCNCC2COC3=CC=CC=C3O2)CC4(CC1=O)CCCC4.Cl |
| EOS-AX7431 | Ro 20-1724 | 29925-17-5 | C15H22N2O3 | 278.35 | O=C(NC1)N[C@H]1CC(C=C2OCCCC)=CC=C2OC |
| EOS-AX7432 | YS-035 hydrochloride | 89805-39-0 | C21H29NO4.HCl | 395.93 | CN(CCC(C=C1OC)=CC=C1OC)CCC(C=C2OC)=CC=C2OC.Cl |
| EOS-AX7433 | GBR 13069 dihydrochloride | 67469-45-8 | C28H30F2N2O.2HCl | 521.48 | FC1=CC=C(C(OCCN2CCN(CC2)C/C([H])=C([H])/C3=CC=CC=C3)C4=CC=C(F)C=C4)C=C1.Cl.Cl |
| EOS-AX7434 | Benzoquinonium dibromide | 311-09-1 | C34H50Br2N4O2 | 706.6 | O=C1C(NCCC[N+](CC)(CC)CC2=CC=CC=C2)=CC(C(NCCC[N+](CC)(CC)CC3=CC=CC=C3)=C1)=O.[Br-].[Br-] |
| EOS-AX7435 | Bromocriptine mesylate | 22260-51-1 | C32H40BrN5O5.CH3SO3H | 750.7 | BrC(NC1=CC=CC2=C31)=C3C[C@H](C2=C4)N(C)C[C@@H]4C(N[C@]5(C(C)C)O[C@@]6(N(C5=O)[C@@H](CC(C)C)C(N7[C@H]6CCC7)=O)O)=O.OS(=O)(C)=O |
| EOS-AX7436 | SC-10 | 102649-79-6 | C17H22ClNO2S | 339.88 | ClC1=C2C(C(S(=O)(NCCCCCCC)=O)=CC=C2)=CC=C1 |
| EOS-AX7437 | ML 9 hydrochloride | 105637-50-1 | C15H17ClN2O2S.HCl | 361.29 | ClC1=C2C(C(S(=O)(N3CCCNCC3)=O)=CC=C2)=CC=C1.Cl |
| EOS-AX7438 | MY-5445 | 78351-75-4 | C20H14ClN3 | 331.8 | ClC1=CC(NC2=NN=C(C3=CC=CC=C3)C4=C2C=CC=C4)=CC=C1 |
| EOS-AX7439 | SC-9 | 102649-78-5 | C22H24ClNO2S | 401.95 | ClC1=C2C(C(S(=O)(NCCCCCCC3=CC=CC=C3)=O)=CC=C2)=CC=C1 |
| EOS-AX7440 | Cimaterol | 54239-37-1 | C12H17N3O | 219.29 | O[C@H](C(C=C1C#N)=CC=C1N)CNC(C)C |
| EOS-AX7441 | Etazolate hydrochloride | 35838-58-5 | C14H19N5O2.HCl | 325.8 | O=C(C1=CN=C2N(CC)N=CC2=C1N/N=C(C)\C)OCC.Cl |
| EOS-AX7442 | DPCPX | 102146-07-6 | C16H24N4O2 | 304.39 | O=C1N(CCC)C(N(CCC)C2=C1NC(C3CCCC3)=N2)=O |
| EOS-AX7443 | m-Chlorophenylbiguanide hydrochloride | 2113-05-5 | C8H10ClN5.HCl | 248.11 | ClC1=CC(/N=C(N)/N=C(N)/N)=CC=C1.Cl |
| EOS-AX7444 | 6-Chloromelatonin | 63762-74-3 | C13H15ClN2O2 | 266.73 | ClC1=C(C=C2C(CCNC(C)=O)=CNC2=C1)OC |
| EOS-AX7445 | 5-Carboxamidotryptamine maleate | 74885-72-6 | C11H13N3O.C4H4O4 | 319.32 | NCCC1=CNC2=C1C=C(C(O)=N)C=C2.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX7446 | Cinanserin hydrochloride | 54-84-2 | C20H24N2OS.HCl | 376.94 | O=C(/C=C/C1=CC=CC=C1)NC2=CC=CC=C2SCCCN(C)C.Cl |
| EOS-AX7447 | N1,N11-Diethylnorspermine tetrahydrochloride | 156886-85-0 | C13H32N4.4HCl | 390.27 | CCNCCCNCCCNCCCNCC.Cl.Cl.Cl.Cl |
| EOS-AX7448 | Nitrocaramiphen hydrochloride | 98636-73-8 | C18H26N2O4.HCl | 370.88 | O=C(C1(C(C=C2)=CC=C2[N+]([O-])=O)CCCC1)OCCN(CC)CC.Cl |
| EOS-AX7449 | (+)-U-50488 hydrochloride | 114528-81-3 | C19H26Cl2N2O.HCl | 405.79 | CN(C(CC1=CC(Cl)=C(Cl)C=C1)=O)[C@]2([H])CCCC[C@@]2([H])N3CCCC3.Cl |
| EOS-AX7450 | Dihydroergocristine mesylate | 24730-10-7 | C35H41N5O5.CH3SO3H | 707.84 | OS(=O)(C)=O.O[C@@]1(N(C2=O)[C@@H](CC3=CC=CC=C3)C(N4[C@H]1CCC4)=O)O[C@]2(C(C)C)NC([C@H]5C[C@@H]6[C@H](CC7=CNC8=CC=CC6=C78)N(C)C5)=O |
| EOS-AX7451 | 2,4-Diamino-6-hydroxypyrimidine | 56-06-4 | C4H6N4O | 126.12 | O=C1N=C(N)NC(N)=C1 |
| EOS-AX7452 | (±)-Decanoylcarnitine chloride | 14919-36-9 | C17H34ClNO4 | 351.91 | O=C(CCCCCCCCC)O[C@H](CC(O)=O)C[N+](C)(C)C.[Cl-] |
| EOS-AX7453 | Dilazep dihydrochloride | 20153-98-4 | C31H44N2O10.2HCl | 677.62 | O=C(C(C=C1OC)=CC(OC)=C1OC)OCCCN2CCN(CCCOC(C(C=C3OC)=CC(OC)=C3OC)=O)CCC2.Cl.Cl |
| EOS-AX7454 | 4-DAMP | 1952-15-4 | C21H26INO2 | 451.33 | O=C(C(C1=CC=CC=C1)C2=CC=CC=C2)OC3CC[N+](C)(C)CC3.[I-] |
| EOS-AX7455 | Dioctanoylglycol | 627-86-1 | C18H34O4 | 314.46 | O=C(CCCCCCC)OCCOC(CCCCCCC)=O |
| EOS-AX7456 | Alrestatin | 51411-04-2 | C14H9NO4 | 255.23 | O=C(C1=CC=CC2=CC=CC3=C12)N(CC(O)=O)C3=O |
| EOS-AX7457 | 1,3-Dipropyl-8-phenylxanthine | 85872-53-3 | C17H20N4O2 | 312.37 | CCCN(C1=O)C2=C(N=C(N2)C3=CC=CC=C3)C(N1CCC)=O |
| EOS-AX7458 | (±)-U-50488 hydrochloride | 67197-96-0 | C19H26Cl2N2O.HCl | 405.79 | CN(C(CC1=CC(Cl)=C(Cl)C=C1)=O)[C@]2([H])CCCC[C@@]2([H])N3CCCC3.Cl |
| EOS-AX7459 | (-)-U-50488 hydrochloride | 114528-79-9 | C19H26Cl2N2O.HCl | 405.79 | CN(C(CC1=CC(Cl)=C(Cl)C=C1)=O)[C@]2([H])CCCC[C@@]2([H])N3CCCC3.Cl |
| EOS-AX7460 | AG 99 | 122520-85-8 | C10H8N2O3 | 204.18 | OC1=CC(/C=C(C#N)\C(N)=O)=CC=C1O |
| EOS-AX7461 | U-54494A hydrochloride | 112465-94-8 | C18H24Cl2N2O.HCl | 391.77 | ClC1=CC(C(N(C)[C@@H]2[C@@H](CCCC2)N3CCCC3)=O)=CC=C1Cl.Cl |
| EOS-AX7462 | N1,N12-Diethylspermine tetrahydrochloride | 113812-15-0 | C14H34N4.4HCl | 404.29 | CCNCCCNCCCCNCCCNCC.Cl.Cl.Cl.Cl |
EOS Med Chem, Medicinal Chemical is Big is China TOP 100 CRO comapny, mainly in Med-chemicals, Custom synthesis. We have GMP, ISO plant plant serving you.
搜索此博客
2017年8月2日星期三
2017.8.3 list 14
订阅:
评论 (Atom)